1
|
Brown L, Marshall A, Conway L, Otter J, Norville P, Clarke J. Assessing the stability and sporicidal efficacy of oxidising disinfectants. J Hosp Infect 2024:S0195-6701(24)00151-8. [PMID: 38705474 DOI: 10.1016/j.jhin.2024.04.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2024] [Revised: 04/10/2024] [Accepted: 04/14/2024] [Indexed: 05/07/2024]
Abstract
The role of the healthcare environment in the transmission of clinical pathogens is well established. We investigated the chemical stability and sporicidal efficacy of oxidising disinfectant products in the presence of simulated clean and medical dirty conditions. Performance of chlorine-releasing agents (sodium dichloroisocyanurate, chlorine dioxide and hypochlorous acid) was concentration-dependent, with 1000 ppm chlorine showing reduced stability and efficacy in dirty conditions. In contrast peracetic acid product demonstrated stability and consistently achieved efficacy in dirty conditions. These results have implications for clinical practice, as ineffective environmental decontamination may increase the risk of transmission of pathogens that can cause healthcare-associated infections.
Collapse
Affiliation(s)
- L Brown
- Fellows Research Centre, North Dean Business Park, Stainland Rd, Greetland, Halifax, Gama Healthcare Ltd, UK.
| | - A Marshall
- Fellows Research Centre, North Dean Business Park, Stainland Rd, Greetland, Halifax, Gama Healthcare Ltd, UK
| | - L Conway
- Fellows Research Centre, North Dean Business Park, Stainland Rd, Greetland, Halifax, Gama Healthcare Ltd, UK
| | - J Otter
- Directorate of Infection, Guy's and St. Thomas NHS Foundation Trust, St Thomas' Hospital, London, UK; National Institute for Healthcare Research Health Protection Research Unit (NIHR HPRU) in HCAI and AMR, Imperial College London & Public Health England, Hammersmith Hospital, London, UK
| | - P Norville
- Fellows Research Centre, North Dean Business Park, Stainland Rd, Greetland, Halifax, Gama Healthcare Ltd, UK
| | - J Clarke
- Fellows Research Centre, North Dean Business Park, Stainland Rd, Greetland, Halifax, Gama Healthcare Ltd, UK
| |
Collapse
|
2
|
Clarke J, Lim A, Gupte P, Pigott DM, van Panhuis WG, Brady OJ. A global dataset of publicly available dengue case count data. Sci Data 2024; 11:296. [PMID: 38485954 PMCID: PMC10940302 DOI: 10.1038/s41597-024-03120-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2023] [Accepted: 03/04/2024] [Indexed: 03/18/2024] Open
Abstract
OpenDengue is a global database of dengue case data collated from public sources and standardised and formatted to facilitate easy reanalysis. Dataset version 1.2 of this database contains information on over 56 million dengue cases from 102 countries between 1924 and 2023, making it the largest and most comprehensive dengue case database currently available. Over 95% of records are at the weekly or monthly temporal resolution and subnational data is available for 40 countries. To build OpenDengue we systematically searched databases, ministry of health websites, peer reviewed literature and Pro-MED mail reports and extracted denominator-based case count data. We undertake standardisation and error checking protocols to ensure consistency and resolve discrepancies. We meticulously documented the extraction process to ensure records are attributable and reproducible. The OpenDengue database remains under development with plans for further disaggregation and user contributions are encouraged. This new dataset can be used to better understand the long-term drivers of dengue transmission, improve estimates of disease burden, targeting and evaluation of interventions and improving future projections.
Collapse
Affiliation(s)
- J Clarke
- Department of Infectious Disease Epidemiology and Dynamics, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK
- Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK
| | - A Lim
- Department of Infectious Disease Epidemiology and Dynamics, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK
- Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK
| | - P Gupte
- Department of Infectious Disease Epidemiology and Dynamics, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK
- Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK
| | - D M Pigott
- Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA
- Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA, USA
| | - W G van Panhuis
- National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
| | - O J Brady
- Department of Infectious Disease Epidemiology and Dynamics, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK.
- Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK.
| |
Collapse
|
3
|
Jabbal M, Burt J, Clarke J, Moran M, Walmsley P, Jenkins PJ. Trends in incidence and average waiting time for arthroplasty from 1998-2021: an observational study of 282,367 patients from the Scottish arthroplasty project. Ann R Coll Surg Engl 2024; 106:249-255. [PMID: 37365920 PMCID: PMC10911452 DOI: 10.1308/rcsann.2023.0039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/24/2023] [Indexed: 06/28/2023] Open
Abstract
BACKGROUND Current waiting times for arthroplasty are reported as being the worst on record. This is a combination of increasing demand, the COVID-19 pandemic and longer standing shortage of capacity. The Scottish Arthroplasty Project (SAP) is a National Audit that analyses all joint replacements undertaken in the Scottish NHS and Independent Sector. The aim of this study was to investigate the long-term trend in provision and waiting time for lower limb joint replacement surgery. METHODS All total hip replacements (THR) and total knee replacements (TKR) undertaken in NHS Scotland from 1998 to 2021 were identified. Waiting times data were analysed each year to determine the minimum, maximum, median, mean and standard deviation. RESULTS In 1998, there were 4,224 THR and 2,898 TKR with mean (range, SD) waiting time of 159.5 days (1-1,685, 119.8) and 182.9 days (1-1,946, 130.1). The minimum waiting times were both in 2013 for 7,612 THR - 78.8 days (0-539, 46) and 7,146 TKR - 79.1 days (0-489, 43.7). The maximum waiting times recorded were in 2021 with 4,070 THR waiting 283.7 days (0-945, 215) and 3,153 TKR waiting 316.8 days (4-1,064, 217). CONCLUSIONS This is the first robust large-scale national dataset showing trends in incidence and waiting time for THR and TKR over two decades. There was an expansion of activity with a reduction in waiting time, which peaked in 2013, followed by an increase in waiting time with a plateau and modest decline in the number of procedures.
Collapse
Affiliation(s)
- M Jabbal
- Royal Infirmary of Edinburgh, UK
| | - J Burt
- Golden Jubilee National Hospital, UK
| | - J Clarke
- Golden Jubilee National Hospital, UK
| | - M Moran
- Royal Infirmary of Edinburgh, UK
| | | | | |
Collapse
|
4
|
Halioua B, Taieb C, Clarke J, Ribeyre C, Merhand S, Demessant-Flavigny AL, Seneschal J. Health literacy and topical corticosteroid adherence in parents of children with atopic dermatitis in France. J Eur Acad Dermatol Venereol 2023; 37:e1417-e1419. [PMID: 37458523 DOI: 10.1111/jdv.19345] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2023] [Accepted: 07/12/2023] [Indexed: 08/02/2023]
Affiliation(s)
- B Halioua
- Private Dermatologist, Dermatologist, Paris, France
| | - C Taieb
- European Market Maintenance Assessment, Fontenay sous-Bois, France
| | - J Clarke
- Communication Médicale, Levallois-Perret, France
| | - C Ribeyre
- Communication Médicale, Levallois-Perret, France
| | - S Merhand
- Association Française de l'Eczéma, Redon, France
| | | | - J Seneschal
- Department of Dermatology and Pediatric Dermatology, National Reference Center for Rare Skin disorders, Hôpital Saint-André, Bordeaux, France
- CNRS, Immuno ConcEpT, UMR 5164, University of Bordeaux, Bordeaux, France
| |
Collapse
|
5
|
Ayrolles A, Bargiacchi A, Clarke J, Michel M, Baillin F, Trebossen V, Kalifa HP, Guilmin-Crépon S, Delorme R, Godart N, Stordeur C. Comparison between continued inpatient treatment versus day patient treatment after short inpatient care in early onset anorexia nervosa (COTIDEA trial): a study protocol for a non-inferiority randomised controlled trial. BMC Psychiatry 2023; 23:730. [PMID: 37817147 PMCID: PMC10563254 DOI: 10.1186/s12888-023-05222-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/19/2023] [Accepted: 09/26/2023] [Indexed: 10/12/2023] Open
Abstract
BACKGROUND In children with early-onset anorexia nervosa (first symptoms before 13 years old, EO-AN), experts recommend initial outpatient treatment but in-patient treatment (IP) is frequently indicated due to acute medical instability or for those who have not improved with outpatient treatment. This IP can target either a partial weight restauration or a total weight normalization (return to the previous BMI growth trajectory). There are no evidence in the literature on which is the better therapeutic option in EOAN. But as long length of stay induce social isolation, with elevated costs, we wonder if a stepped-care model of daypatient treatment (DP) after short IP stabilisation may be a treatment option as effective as full-time IP to target weight normalization. We designed a two-arm randomised controlled trial testing the non-inferiority of a stepped-care model of DP after short IP stabilisation versus full-time IP. METHODS Eighty-eight children aged 8 to 13 years suffering from EOAN with initial severe undernutrition will be randomly allocated to either IP treatment as usual or a stepped care DP model both targeting weight normalization. Assessments will be conducted at inclusion, somatic stabilization, weight normalization, 6 months and 12 months post randomisation. The primary outcome will be BMI at 12 months post-randomisation. Secondaries outcomes will included clinical (tanner stage), biological (prealbumin, leptin, total ghrelin and IGF1) and radiological (bone mineralization and maturation) outcomes, eating symptomatology and psychiatric assessments, motivation to change, treatment acceptability and quality of life assessments, cost-utility and cost-effectiveness analyses. DISCUSSION COTIDEA will provide rigorous evaluation of treatment alternative to full-time inpatient treatment to allow a reduction of social iatrogenic link to hospital length of stay and associated costs. TRIAL REGISTRATION Trial is registered on ClinicalTrials.gov (NCT04479683).
Collapse
Affiliation(s)
- A Ayrolles
- Child and Adolescent Psychiatry Department, Reference Center for Rare Early-Onset Restrictive Eating Disorder, Robert Debré University Hospital, APHP, Paris, France.
- Université Paris Cité, Paris, France.
- Human Genetics & Cognitive Functions, CNRS UMR3571, Institut Pasteur, Paris, France.
| | - A Bargiacchi
- Child and Adolescent Psychiatry Department, Reference Center for Rare Early-Onset Restrictive Eating Disorder, Robert Debré University Hospital, APHP, Paris, France
| | - J Clarke
- Institute of Psychiatry and Neuroscience of Paris, INSERM U1266, Paris, France
- CMME (GHU Paris Psychiatrie Et Neurosciences), Paris Descartes University, Paris, France
| | - M Michel
- Université Paris Cité, Paris, France
- Inserm, ECEVE, U1123, 10 Boulevard de Verdun, 75010, Paris, France
- Department of Clinical Epidemiology, Robert Debré University Hospital, APHP, Paris, France
| | - F Baillin
- Child and Adolescent Psychiatry Department, Reference Center for Rare Early-Onset Restrictive Eating Disorder, Robert Debré University Hospital, APHP, Paris, France
| | - V Trebossen
- Child and Adolescent Psychiatry Department, Reference Center for Rare Early-Onset Restrictive Eating Disorder, Robert Debré University Hospital, APHP, Paris, France
| | - H Poncet Kalifa
- Child and Adolescent Psychiatry Department, Reference Center for Rare Early-Onset Restrictive Eating Disorder, Robert Debré University Hospital, APHP, Paris, France
| | - S Guilmin-Crépon
- Inserm, ECEVE, U1123, 10 Boulevard de Verdun, 75010, Paris, France
- Department of Clinical Epidemiology, Robert Debré University Hospital, APHP, Paris, France
- Pediatric Endocrinology-Diabetology Department, Reference Center for Rare Growth and Development Endocrine Diseases, INSERM NeuroDiderot, Robert Debré University Hospital, APHP, Paris, France
| | - R Delorme
- Child and Adolescent Psychiatry Department, Reference Center for Rare Early-Onset Restrictive Eating Disorder, Robert Debré University Hospital, APHP, Paris, France
- Université Paris Cité, Paris, France
- Human Genetics & Cognitive Functions, CNRS UMR3571, Institut Pasteur, Paris, France
| | - N Godart
- CESP, INSERM, UMR 1018, University Paris-Sud, UVSQ, University Paris-Saclay, Villejuif, France
- UFR Simone Veil, UVSQ, University Paris-Saclay, Montigny-Le-Bretonneux, France
- Fondation de Santé Des Etudiants de France, Paris, France
| | - C Stordeur
- Child and Adolescent Psychiatry Department, Reference Center for Rare Early-Onset Restrictive Eating Disorder, Robert Debré University Hospital, APHP, Paris, France
| |
Collapse
|
6
|
Vaios EJ, Shenker RF, Hendrickson P, Wan Z, Niedzwiecki D, Winter SF, Dietrich J, Salama AKS, Clarke J, Allen KJ, Mullikin TC, Floyd SR, Kirkpatrick JP, Reitman ZJ. Intracranial Control with Combined Dual Immune-Checkpoint Blockade and SRS for Melanoma and NSCLC Brain Metastases. Int J Radiat Oncol Biol Phys 2023; 117:S171-S172. [PMID: 37784428 DOI: 10.1016/j.ijrobp.2023.06.637] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) It is unknown whether the use of dual immune-checkpoint inhibition (D-ICI) combined with stereotactic radiosurgery (SRS) affects local control of brain metastases (BMs). We sought to characterize the efficacy of SRS and D-ICI in patients with BMs in a large, single-institution cohort. MATERIALS/METHODS Patients with melanoma and non-small cell lung cancer (NSCLC) BMs treated with SRS from January 1, 2016 to August 1, 2022 were evaluated. Patients were stratified by treatment with D-ICI versus single ICI (S-ICI). Concurrent ICI was defined as ICI given within four weeks of SRS. Local recurrence (LR), intracranial progression (IP), and overall survival (OS) were estimated using competing risk and Kaplan-Meier analyses. IP included both local and distant intracranial recurrence. RESULTS One thousand seven hundred four SRS-treated BMs from 288 patients met inclusion criteria. 55% of patients were symptomatic from their BMs at presentation. Median age, KPS, number of lesions, and SRS courses were 64 (Q1Q3:56-70.5), 90 (80-90), 2 (1-4), and 1 (1-2), respectively. One hundred twenty-eight (44%) melanoma and 160 (56%) NSCLC patients were included. 82 (28.5%), 129 (44.8%), and 77 (26.7%) patients were treated with D-ICI, S-ICI, or SRS alone. Median SRS dose, fractions, and PTV were 20 (Q1Q3:20-25), 1 (1-5), and 0.3cc3 (0.1-1.2). The median follow-up was 14.3 months. One hundred twenty-seven (7.45%) BMs recurred post-SRS and the median time to LR was 4.8 months (Q1Q3:3.0-9.2). On competing risk analysis, LR was significantly reduced with D-ICI (HR: 0.452, p = 0.0024), but not with S-ICI (HR: 0.693, p = 0.0596) compared to SRS alone. The 1-year LR was 3.77% (95% CI = 2.19-6.00), 6.8% (5.19-8.70), and 8.96% (6.48-11.93) with D-ICI, S-ICI, and SRS alone. The median time to IP was 4.1 months (Q1Q3 = 2.9-9.5). On competing risk analysis, IP was significantly reduced with D-ICI (HR = 0.638, p = 0.031), but not with S-ICI (HR = 0.756, p = 0.106) compared to SRS alone. 1-year IP was 40.05% (95% CI = 29.14-50.70), 51.86% (42.78-60.19), and 58.49% (46.30-68.84) with D-ICI, S-ICI, and SRS alone. Concurrent delivery of D-ICI and SRS significantly reduced IP (HR = 0.463, p = 0.0071), whereas other combinations of timing and ICI did not reach significance. Median OS was 11.9 months after SRS. On Kaplan Meier analysis, OS was significantly improved with D-ICI (HR = 0.616, 95% CI = 0.412-0.923, p = 0.019), but not with S-ICI (HR = 0.877, 95% CI = 0.633-1.217, p = 0.433) compared to SRS alone. Hospitalizations (p = 0.021) and immune-related adverse events (irAEs) (p<0.001) were increased with D-ICI. Any grade radiation necrosis (RN) was also increased with D-ICI (p = 0.013), but neurologic adverse events were comparable across cohorts (p = 0.572). CONCLUSION D-ICI combined with SRS was associated with improved local control, intracranial control, and overall survival compared to SRS alone, whereas S-ICI was not associated with an improvement in these outcomes. However, D-ICI was also associated with increased risks of irAEs and RN.
Collapse
Affiliation(s)
- E J Vaios
- Duke University, Durham, NC; Department of Radiation Oncology, Duke University Medical Center, Durham, NC
| | - R F Shenker
- Department of Radiation Oncology, Duke University Medical Center, Durham, NC
| | - P Hendrickson
- Department of Radiation Oncology, Duke University, Durham, NC
| | - Z Wan
- Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC
| | - D Niedzwiecki
- Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC
| | - S F Winter
- Massachusetts General Hospital, Boston, MA
| | - J Dietrich
- Massachusetts General Hospital, Boston, MA
| | | | - J Clarke
- Duke University, Department of Medical Oncology, Durham, NC
| | - K J Allen
- Department of Radiation Oncology, Duke University Medical Center, Durham, NC
| | - T C Mullikin
- Department of Radiation Oncology, Duke University, Rochester, MN
| | - S R Floyd
- Duke University Medical Center, Durham, NC
| | - J P Kirkpatrick
- Department of Radiation Oncology, Duke University Medical Center, Durham, NC
| | - Z J Reitman
- Harvard Radiation Oncology Program, Boston, MA
| |
Collapse
|
7
|
Clarke J, Neveu P, Khosla KE, Verhagen E, Vanner MR. Cavity Quantum Optomechanical Nonlinearities and Position Measurement beyond the Breakdown of the Linearized Approximation. Phys Rev Lett 2023; 131:053601. [PMID: 37595248 DOI: 10.1103/physrevlett.131.053601] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/22/2022] [Revised: 05/05/2023] [Accepted: 06/28/2023] [Indexed: 08/20/2023]
Abstract
Several optomechanics experiments are now entering the highly sought nonlinear regime where optomechanical interactions are large even for low light levels. Within this regime, new quantum phenomena and improved performance may be achieved; however, a corresponding theoretical formalism of cavity quantum optomechanics that captures the nonlinearities of both the radiation-pressure interaction and the cavity response is needed to unlock these capabilities. Here, we develop such a nonlinear cavity quantum optomechanical framework, which we then utilize to propose how position measurement can be performed beyond the breakdown of the linearized approximation. Our proposal utilizes optical general-dyne detection, ranging from single to dual homodyne, to obtain mechanical position information imprinted onto both the optical amplitude and phase quadratures and enables both pulsed and continuous modes of operation. These cavity optomechanical nonlinearities are now being confronted in a growing number of experiments, and our framework will allow a range of advances to be made in, e.g., quantum metrology, explorations of the standard quantum limit, and quantum measurement and control.
Collapse
Affiliation(s)
- J Clarke
- QOLS, Blackett Laboratory, Imperial College London, London SW7 2BW, United Kingdom
| | - P Neveu
- Center for Nanophotonics, AMOLF, Science Park 104, 1098 XG Amsterdam, The Netherlands
| | - K E Khosla
- QOLS, Blackett Laboratory, Imperial College London, London SW7 2BW, United Kingdom
| | - E Verhagen
- Center for Nanophotonics, AMOLF, Science Park 104, 1098 XG Amsterdam, The Netherlands
| | - M R Vanner
- QOLS, Blackett Laboratory, Imperial College London, London SW7 2BW, United Kingdom
| |
Collapse
|
8
|
Ayrolles A, Clarke J, Dechaux M, Lefebvre A, Cohen A, Stordeur C, Peyre H, Bargiacchi A, Godart N, Watson H, Delorme R. Inpatient target discharge weight for early-onset anorexia nervosa: Restoring premorbid BMI percentile to improve height prognosis. Clin Nutr ESPEN 2023; 54:150-156. [PMID: 36963857 DOI: 10.1016/j.clnesp.2023.01.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2022] [Revised: 10/11/2022] [Accepted: 01/20/2023] [Indexed: 01/26/2023]
Abstract
OBJECTIVE Early-onset anorexia nervosa (EO-AN) is characterized by restricted food intake leading to low body weight, emerging before 14 years old. Most patients reaching a target body mass index (BMI) around the 25th percentile at hospitalization discharge display an incomplete prospective height catch-up. A better understanding of height prognosis determinants is required. METHODS In 74 children with an EO-AN, we collected height and weight premorbidly, at hospitalization, and at discharge, 6 months, 12 months, and at longer-term follow-up of 36 months. We defined a height prognosis parameter (HPP) as the difference between the height percentile at follow-up times and the premorbid height percentile. We explored the relationship between weight parameters and height catch-up at follow-up with linear regression analyses. RESULTS A higher weight suppression (WS) - i.e., difference between premorbid and current BMI - at admission and discharge was associated with lower HPP - i.e., a greater loss of height - at 12 months and 36 months follow-up. Similarly, a higher premorbid BMI percentile was associated with a lower HPP at 12 and 36 months. CONCLUSION Target discharge weight for EO-AN patients should be tailored and based on premorbid BMI trajectory to improve height prognosis.
Collapse
Affiliation(s)
- A Ayrolles
- Assistance Publique - Hôpitaux de Paris, Robert Debré Hospital, Child and Adolescent Psychiatry Department, Paris, France; Human Genetics & Cognitive Functions, Institut Pasteur, Paris, France.
| | - J Clarke
- Assistance Publique - Hôpitaux de Paris, Robert Debré Hospital, Child and Adolescent Psychiatry Department, Paris, France; Centre of Psychiatry and Neuroscience, INSERM UMR 894, Paris, France
| | - M Dechaux
- Assistance Publique - Hôpitaux de Paris, Robert Debré Hospital, Child and Adolescent Psychiatry Department, Paris, France
| | - A Lefebvre
- Assistance Publique - Hôpitaux de Paris, Robert Debré Hospital, Child and Adolescent Psychiatry Department, Paris, France; Human Genetics & Cognitive Functions, Institut Pasteur, Paris, France
| | - A Cohen
- Assistance Publique - Hôpitaux de Paris, Robert Debré Hospital, Child and Adolescent Psychiatry Department, Paris, France
| | - C Stordeur
- Assistance Publique - Hôpitaux de Paris, Robert Debré Hospital, Child and Adolescent Psychiatry Department, Paris, France
| | - H Peyre
- Assistance Publique - Hôpitaux de Paris, Robert Debré Hospital, Child and Adolescent Psychiatry Department, Paris, France; INSERM UMRS 1141, Paris, France; Paris University, Paris, France
| | - A Bargiacchi
- Assistance Publique - Hôpitaux de Paris, Robert Debré Hospital, Child and Adolescent Psychiatry Department, Paris, France
| | - N Godart
- Fondation Santé des Etudiants de France, Paris, France; CESP, U1018, INSERM, Villejuif, France; UFR of Health Sciences, UVSQ, Versailles, France
| | - H Watson
- Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, USA; School of Psychology, Curtin University, Perth, Australia; School of Paediatrics, Division of Medicine, The University of Western Australia, Perth, Australia
| | - R Delorme
- Assistance Publique - Hôpitaux de Paris, Robert Debré Hospital, Child and Adolescent Psychiatry Department, Paris, France; Human Genetics & Cognitive Functions, Institut Pasteur, Paris, France; Paris University, Paris, France
| |
Collapse
|
9
|
Villaruz LC, Wang X, Bertino EM, Gu L, Antonia SJ, Burns TF, Clarke J, Crawford J, Evans TL, Friedland DM, Otterson GA, Ready NE, Wozniak AJ, Stinchcombe TE. A single-arm, multicenter, phase II trial of osimertinib in patients with epidermal growth factor receptor exon 18 G719X, exon 20 S768I, or exon 21 L861Q mutations. ESMO Open 2023; 8:101183. [PMID: 36905787 PMCID: PMC10163152 DOI: 10.1016/j.esmoop.2023.101183] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2022] [Revised: 02/08/2023] [Accepted: 02/12/2023] [Indexed: 03/11/2023] Open
Abstract
BACKGROUND For patients with stage IV non-small-cell lung cancer with epidermal growth factor receptor (EGFR) exon 19 deletions and exon 21 L858R mutations, osimertinib is the standard of care. Investigating the activity and safety of osimertinib in patients with EGFR exon 18 G719X, exon 20 S768I, or exon 21 L861Q mutations is of clinical interest. PATIENTS AND METHODS Patients with stage IV non-small-cell lung cancer with confirmed EGFR exon 18 G719X, exon 20 S768I, or exon 21 L861Q mutations were eligible. Patients were required to have measurable disease, an Eastern Cooperative Oncology Group performance status of 0 or 1, and adequate organ function. Patients were required to be EGFR tyrosine kinase inhibitor-naive. The primary objective was objective response rate, and secondary objectives were progression-free survival, safety, and overall survival. The study used a two-stage design with a plan to enroll 17 patients in the first stage, and the study was terminated after the first stage due to slow accrual. RESULTS Between May 2018 and March 2020, 17 patients were enrolled and received study therapy. The median age of patients was 70 years (interquartile range 62-76), the majority were female (n = 11), had a performance status of 1 (n = 10), and five patients had brain metastases at baseline. The objective response rate was 47% [95% confidence interval (CI) 23% to 72%], and the radiographic responses observed were partial response (n = 8), stable disease (n = 8), and progressive disease (n = 1). The median progression-free survival was 10.5 months (95% CI 5.0-15.2 months), and the median OS was 13.8 months (95% CI 7.3-29.2 months). The median duration on treatment was 6.1 months (range 3.6-11.9 months), and the most common adverse events (regardless of attribution) were diarrhea, fatigue, anorexia, weight loss, and dyspnea. CONCLUSIONS This trial suggests osimertinib has activity in patients with these uncommon EGFR mutations.
Collapse
Affiliation(s)
- L C Villaruz
- UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh
| | - X Wang
- Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham
| | - E M Bertino
- Division of Medical Oncology, The Ohio State University James Comprehensive Cancer Center, Columbus
| | - L Gu
- Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham
| | | | - T F Burns
- UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh
| | - J Clarke
- Duke Cancer Institute, Durham, USA
| | | | - T L Evans
- UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh
| | - D M Friedland
- UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh
| | - G A Otterson
- Division of Medical Oncology, The Ohio State University James Comprehensive Cancer Center, Columbus
| | | | - A J Wozniak
- UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh
| | | |
Collapse
|
10
|
Clarke J. Establishing a baseline of learning & development of pharmacy professionals in general practice within Bristol, North Somerset & South Gloucestershire. International Journal of Pharmacy Practice 2022. [DOI: 10.1093/ijpp/riac089.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/02/2022]
Abstract
Abstract
Introduction
The number of pharmacists and pharmacy technicians working within general practice has significantly increased with the NHS Long Term Plan and the introduction of the ‘Additional Roles Reimbursement Scheme’ (ARRS)1,2. Whilst there is an approved learning pathway for those employed under ARRS3, it is not clear what additional development the whole local workforce needed both immediately and into the future.
Aim
To establish what learning & development was being completed by the pharmacy professionals in general practice and what was required to support the roles into the future.
Methods
An online, anonymous survey was sent to all members of the pharmacy workforce working in GP practices or Primary Care Networks across Bristol, North Somerset & South Gloucestershire (119 pharmacists and 36 pharmacy technicians). The tool used a mixture of qualitative and quantitative questions to investigate existing learning needs, current programmes of study and the use of competency frameworks to support learning. In addition, it investigated whether respondents used ‘communities of practice’ to support their learning and what future networks may be required. Qualitative data were grouped by themes and actions taken on the key themes. Descriptive statistical analysis was undertaken on the quantitative data. The survey was not considered to be research; therefore ethics approval was not required.
Results
There was a 25% response rate (n=39) which included 29 pharmacists (24%) and 10 pharmacy technicians (28%). 15 respondents were either on the accredited pathway or had completed it (38%) and of the pharmacists, 20 were registered prescribers (69%). 21% (n=8) of respondents were using a framework to evidence competencies. Career aspirations included becoming Advanced Clinical Practitioners, Consultant Pharmacists or Partners in their practice. 44% (n=17) of respondents reported no protected development time. 30 respondents belong to one or more network groups (81%). 73% (n=28) of the respondents supported the development of more communities of practice although some suggested the purpose should be clear and the impact on work-life balance considered.
Discussion/Conclusion
This study provided a broad overview of the current need for learning and development in the local area although a limitation was the small proportion of the workforce that responded. It was clear that the pharmacy workforce in general practice in BNSSG required more support for career development. The information gathered through this survey has shaped the support provided by the Pharmacy Lead at the BNSSG Training Hub. Guidance has been produced to support practices with understanding roles of pharmacy professionals and their development needs including protected time. A business case has been submitted to explore funding for advanced clinical skills as this was seen as a priority by respondents. In addition, an additional community of practice has been developed to enable peer discussions and support amongst pharmacy professionals. There is further work to be done to support the learning and development of the workforce in general practice. The Royal Pharmaceutical Society Core Advanced Curriculum and the use of already established frameworks will enable pharmacy professionals to demonstrate their skills and competence and will be used to identify their learning needs.
References
1. NHS. The NHS Long Term Plan. 2019. Available from https://www.longtermplan.nhs.uk/ [Accessed 22 July 2022]
2. Wickware C. Number of pharmacists in primary care training increases by almost 50% in a year. The Pharmaceutical Journal [Internet]. 2021 July [cited 2021 July];307(7951). Available from Number of pharmacists in primary care training increases by almost 50% in a year - The Pharmaceutical Journal (pharmaceutical-journal.com) [Accessed 22 July 2022]
3. Centre for Pharmacy Postgraduate Education (CPPE). Primary Care Pharmacy Education Pathway (PCPEP). Available from Primary care pharmacy education pathway: CPPE [Accessed 22 July 2022]
Collapse
Affiliation(s)
- J Clarke
- Bristol, North Somerset & South Gloucestershire (BNSSG) Training Hub
| |
Collapse
|
11
|
Vaios E, Shenker R, Hendrickson P, D'Anna R, Niedzwiecki D, Carpenter D, Floyd W, Winter S, Dietrich J, Floyd S, Kirkpatrick J, Mullikin T, Allen K, Salama A, Clarke J, Reitman Z. Impact of Single and Dual Immune Checkpoint Blockade on Risk of Radiation Necrosis among Patients with Brain Metastases Treated with Stereotactic Radiosurgery. Int J Radiat Oncol Biol Phys 2022. [DOI: 10.1016/j.ijrobp.2022.07.855] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
12
|
Alboksmaty A, Beaney T, Elkin S, Clarke J, Darzi A, Aylin P, Neves AL. Effectiveness and safety of pulse oximetry in remote patient monitoring of patients with COVID-19. Eur J Public Health 2022. [PMCID: PMC9593659 DOI: 10.1093/eurpub/ckac129.303] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/02/2022] Open
Abstract
Context A surge of COVID cases globally is often portrayed as “very likely”, which overwhelms health systems and challenges their capacities. A mitigation strategy is seen by remotely monitoring COVID patients in out-of-hospital settings to determine the risk of deterioration. Description of the problem We need an indicator to enable remote monitoring of COVID patients at home that can be measured by a handy tool; pulse oximetry which measures peripheral blood oxygen saturation (SpO2). Evidence shows that SpO2 is a reliable indicator of deterioration among COVID patients. The UK initiated a national programme (COVID Oximetry @ Home (CO@H)) to assess the theory. The concept can be potentially applied in other countries in various settings. As part of CO@H, we conducted a systematic review of the evidence on the safety and effectiveness of pulse oximetry in remote monitoring of COVID patients. Results Our review confirms the safety and potential effectiveness of pulse oximetry in remote home monitoring among COVID patients. We identified 13 research projects involving 2,908 participants that assessed the proposed strategy. Evidence shows the need to monitor at-rest and post-exertional SpO2. At-rest SpO2 of ≤ 92% or a decrease of 5% or more in post-exertional SpO2 should indicate care escalation. The recommended method for measuring at-rest SpO2 is after 5-10 min of rest, and assessing post-exertional SpO2 is after conducting a 1-min sit-to-stand test. We could not find explicit evidence on the impact on health service use compared with other models of care. Lessons Remote monitoring of COVID patients could alleviate the pressure on health systems and save hospital resources. Monitoring SpO2 by pulse oximetry can be widely applied, including in resource-limited settings, as the tool is affordable, reliable, and easy to use. Key messages • Adopting relevant health technologies in remote patient monitoring is critical to combat the pandemic. • Pulse oximetry is an affordable, easy to use and widely available tool to monitor patients with COVID-19 at home.
Collapse
Affiliation(s)
- A Alboksmaty
- Department of Primary Care and Public Health, Imperial College London , London, UK
- PSTRC, Imperial College London , London, UK
| | - T Beaney
- PSTRC, Imperial College London , London, UK
| | - S Elkin
- PSTRC, Imperial College London , London, UK
| | - J Clarke
- PSTRC, Imperial College London , London, UK
| | - A Darzi
- PSTRC, Imperial College London , London, UK
| | - P Aylin
- Department of Primary Care and Public Health, Imperial College London , London, UK
- PSTRC, Imperial College London , London, UK
| | - AL Neves
- PSTRC, Imperial College London , London, UK
| |
Collapse
|
13
|
Fullwood I, Evans T, Davies B, Ninan T, Onyon C, Clarke J, Srikanthiah R, Frost S, Iqbal N, Atkinson M, Rao S, Nagakumar P. Do you know when the inhaler is empty? Arch Dis Child 2022; 107:902-905. [PMID: 35551051 DOI: 10.1136/archdischild-2022-324027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/18/2022] [Accepted: 04/28/2022] [Indexed: 11/04/2022]
Abstract
BACKGROUND Medication review is recommended at asthma appointments. The presence of propellant in the metered dose inhalers (MDIs) makes it challenging to identify when the inhaler is empty. The COVID-19 pandemic has resulted in move towards more virtual monitoring of care. We aimed to evaluate if patients identify when the inhaler is empty and the method of inhaler disposal. METHODS Prospective, multicentre quality improvement project. Data collected from children with asthma and other respiratory conditions. OUTCOME MEASURES Children/carers attending hospital were asked how they identify an empty salbutamol inhaler; dose counters in the preventer inhalers and disposal practices were reviewed. RESULTS 157 patients recruited. 125 (73.5%) patients deemed an empty inhaler as either full/partially full. 12 of 66 (18.2%) preventer inhalers with a dose counter were empty. 83% disposed their inhalers in a dustbin. CONCLUSIONS Patients cannot reliably identify when their MDI is empty. There is an urgent need for improving inhaler technology and providing appropriate guidance on how to identify when an MDI is empty.
Collapse
Affiliation(s)
- I Fullwood
- Department of Respiratory Medicine, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK
| | - T Evans
- Department of Respiratory Medicine, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK
| | - Benjamin Davies
- Department of Respiratory Medicine, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK
| | - T Ninan
- Department of Paediatrics, University Hospitals of Birmingham NHS Trust, Birmingham, United Kingdom, Birmingham, UK
| | - C Onyon
- Department of Paediatrics, Worcestershire Acute Hospitals NHS Trust, Worcester, UK
| | - J Clarke
- Department of Paediatrics, Wye Valley NHS Trust, Hereford, UK
| | - Rajesh Srikanthiah
- Department of Paediatrics, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK
| | - Susan Frost
- Department of Respiratory Medicine, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK
| | - N Iqbal
- Department of Paediatrics, Walsall Hospitals NHS Trust, Walsall, UK
| | - M Atkinson
- Department of Paediatrics, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK
| | - Satish Rao
- Department of Respiratory Medicine, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK
| | - Prasad Nagakumar
- Department of Respiratory Medicine, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK
- Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK
| |
Collapse
|
14
|
Evans RA, Leavy OC, Richardson M, Elneima O, McAuley HJC, Shikotra A, Singapuri A, Sereno M, Saunders RM, Harris VC, Houchen-Wolloff L, Aul R, Beirne P, Bolton CE, Brown JS, Choudhury G, Diar-Bakerly N, Easom N, Echevarria C, Fuld J, Hart N, Hurst J, Jones MG, Parekh D, Pfeffer P, Rahman NM, Rowland-Jones SL, Shah AM, Wootton DG, Chalder T, Davies MJ, De Soyza A, Geddes JR, Greenhalf W, Greening NJ, Heaney LG, Heller S, Howard LS, Jacob J, Jenkins RG, Lord JM, Man WDC, McCann GP, Neubauer S, Openshaw PJM, Porter JC, Rowland MJ, Scott JT, Semple MG, Singh SJ, Thomas DC, Toshner M, Lewis KE, Thwaites RS, Briggs A, Docherty AB, Kerr S, Lone NI, Quint J, Sheikh A, Thorpe M, Zheng B, Chalmers JD, Ho LP, Horsley A, Marks M, Poinasamy K, Raman B, Harrison EM, Wain LV, Brightling CE, Abel K, Adamali H, Adeloye D, Adeyemi O, Adrego R, Aguilar Jimenez LA, Ahmad S, Ahmad Haider N, Ahmed R, Ahwireng N, Ainsworth M, Al-Sheklly B, Alamoudi A, Ali M, Aljaroof M, All AM, Allan L, Allen RJ, Allerton L, Allsop L, Almeida P, Altmann D, Alvarez Corral M, Amoils S, Anderson D, Antoniades C, Arbane G, Arias A, Armour C, Armstrong L, Armstrong N, Arnold D, Arnold H, Ashish A, Ashworth A, Ashworth M, Aslani S, Assefa-Kebede H, Atkin C, Atkin P, Aung H, Austin L, Avram C, Ayoub A, Babores M, Baggott R, Bagshaw J, Baguley D, Bailey L, Baillie JK, Bain S, Bakali M, Bakau M, Baldry E, Baldwin D, Ballard C, Banerjee A, Bang B, Barker RE, Barman L, Barratt S, Barrett F, Basire D, Basu N, Bates M, Bates A, Batterham R, Baxendale H, Bayes H, Beadsworth M, Beckett P, Beggs M, Begum M, Bell D, Bell R, Bennett K, Beranova E, Bermperi A, Berridge A, Berry C, Betts S, Bevan E, Bhui K, Bingham M, Birchall K, Bishop L, Bisnauthsing K, Blaikely J, Bloss A, Bolger A, Bonnington J, Botkai A, Bourne C, Bourne M, Bramham K, Brear L, Breen G, Breeze J, Bright E, Brill S, Brindle K, Broad L, Broadley A, Brookes C, Broome M, Brown A, Brown A, Brown J, Brown J, Brown M, Brown M, Brown V, Brugha T, Brunskill N, Buch M, Buckley P, Bularga A, Bullmore E, Burden L, Burdett T, Burn D, Burns G, Burns A, Busby J, Butcher R, Butt A, Byrne S, Cairns P, Calder PC, Calvelo E, Carborn H, Card B, Carr C, Carr L, Carson G, Carter P, Casey A, Cassar M, Cavanagh J, Chablani M, Chambers RC, Chan F, Channon KM, Chapman K, Charalambou A, Chaudhuri N, Checkley A, Chen J, Cheng Y, Chetham L, Childs C, Chilvers ER, Chinoy H, Chiribiri A, Chong-James K, Choudhury N, Chowienczyk P, Christie C, Chrystal M, Clark D, Clark C, Clarke J, Clohisey S, Coakley G, Coburn Z, Coetzee S, Cole J, Coleman C, Conneh F, Connell D, Connolly B, Connor L, Cook A, Cooper B, Cooper J, Cooper S, Copeland D, Cosier T, Coulding M, Coupland C, Cox E, Craig T, Crisp P, Cristiano D, Crooks MG, Cross A, Cruz I, Cullinan P, Cuthbertson D, Daines L, Dalton M, Daly P, Daniels A, Dark P, Dasgin J, David A, David C, Davies E, Davies F, Davies G, Davies GA, Davies K, Dawson J, Daynes E, Deakin B, Deans A, Deas C, Deery J, Defres S, Dell A, Dempsey K, Denneny E, Dennis J, Dewar A, Dharmagunawardena R, Dickens C, Dipper A, Diver S, Diwanji SN, Dixon M, Djukanovic R, Dobson H, Dobson SL, Donaldson A, Dong T, Dormand N, Dougherty A, Dowling R, Drain S, Draxlbauer K, Drury K, Dulawan P, Dunleavy A, Dunn S, Earley J, Edwards S, Edwardson C, El-Taweel H, Elliott A, Elliott K, Ellis Y, Elmer A, Evans D, Evans H, Evans J, Evans R, Evans RI, Evans T, Evenden C, Evison L, Fabbri L, Fairbairn S, Fairman A, Fallon K, Faluyi D, Favager C, Fayzan T, Featherstone J, Felton T, Finch J, Finney S, Finnigan J, Finnigan L, Fisher H, Fletcher S, Flockton R, Flynn M, Foot H, Foote D, Ford A, Forton D, Fraile E, Francis C, Francis R, Francis S, Frankel A, Fraser E, Free R, French N, Fu X, Furniss J, Garner L, Gautam N, George J, George P, Gibbons M, Gill M, Gilmour L, Gleeson F, Glossop J, Glover S, Goodman N, Goodwin C, Gooptu B, Gordon H, Gorsuch T, Greatorex M, Greenhaff PL, Greenhalgh A, Greenwood J, Gregory H, Gregory R, Grieve D, Griffin D, Griffiths L, Guerdette AM, Guillen Guio B, Gummadi M, Gupta A, Gurram S, Guthrie E, Guy Z, H Henson H, Hadley K, Haggar A, Hainey K, Hairsine B, Haldar P, Hall I, Hall L, Halling-Brown M, Hamil R, Hancock A, Hancock K, Hanley NA, Haq S, Hardwick HE, Hardy E, Hardy T, Hargadon B, Harrington K, Harris E, Harrison P, Harvey A, Harvey M, Harvie M, Haslam L, Havinden-Williams M, Hawkes J, Hawkings N, Haworth J, Hayday A, Haynes M, Hazeldine J, Hazelton T, Heeley C, Heeney JL, Heightman M, Henderson M, Hesselden L, Hewitt M, Highett V, Hillman T, Hiwot T, Hoare A, Hoare M, Hockridge J, Hogarth P, Holbourn A, Holden S, Holdsworth L, Holgate D, Holland M, Holloway L, Holmes K, Holmes M, Holroyd-Hind B, Holt L, Hormis A, Hosseini A, Hotopf M, Howard K, Howell A, Hufton E, Hughes AD, Hughes J, Hughes R, Humphries A, Huneke N, Hurditch E, Husain M, Hussell T, Hutchinson J, Ibrahim W, Ilyas F, Ingham J, Ingram L, Ionita D, Isaacs K, Ismail K, Jackson T, James WY, Jarman C, Jarrold I, Jarvis H, Jastrub R, Jayaraman B, Jezzard P, Jiwa K, Johnson C, Johnson S, Johnston D, Jolley CJ, Jones D, Jones G, Jones H, Jones H, Jones I, Jones L, Jones S, Jose S, Kabir T, Kaltsakas G, Kamwa V, Kanellakis N, Kaprowska S, Kausar Z, Keenan N, Kelly S, Kemp G, Kerslake H, Key AL, Khan F, Khunti K, Kilroy S, King B, King C, Kingham L, Kirk J, Kitterick P, Klenerman P, Knibbs L, Knight S, Knighton A, Kon O, Kon S, Kon SS, Koprowska S, Korszun A, Koychev I, Kurasz C, Kurupati P, Laing C, Lamlum H, Landers G, Langenberg C, Lasserson D, Lavelle-Langham L, Lawrie A, Lawson C, Lawson C, Layton A, Lea A, Lee D, Lee JH, Lee E, Leitch K, Lenagh R, Lewis D, Lewis J, Lewis V, Lewis-Burke N, Li X, Light T, Lightstone L, Lilaonitkul W, Lim L, Linford S, Lingford-Hughes A, Lipman M, Liyanage K, Lloyd A, Logan S, Lomas D, Loosley R, Lota H, Lovegrove W, Lucey A, Lukaschuk E, Lye A, Lynch C, MacDonald S, MacGowan G, Macharia I, Mackie J, Macliver L, Madathil S, Madzamba G, Magee N, Magtoto MM, Mairs N, Majeed N, Major E, Malein F, Malim M, Mallison G, Mandal S, Mangion K, Manisty C, Manley R, March K, Marciniak S, Marino P, Mariveles M, Marouzet E, Marsh S, Marshall B, Marshall M, Martin J, Martineau A, Martinez LM, Maskell N, Matila D, Matimba-Mupaya W, Matthews L, Mbuyisa A, McAdoo S, Weir McCall J, McAllister-Williams H, McArdle A, McArdle P, McAulay D, McCormick J, McCormick W, McCourt P, McGarvey L, McGee C, Mcgee K, McGinness J, McGlynn K, McGovern A, McGuinness H, McInnes IB, McIntosh J, McIvor E, McIvor K, McLeavey L, McMahon A, McMahon MJ, McMorrow L, Mcnally T, McNarry M, McNeill J, McQueen A, McShane H, Mears C, Megson C, Megson S, Mehta P, Meiring J, Melling L, Mencias M, Menzies D, Merida Morillas M, Michael A, Milligan L, Miller C, Mills C, Mills NL, Milner L, Misra S, Mitchell J, Mohamed A, Mohamed N, Mohammed S, Molyneaux PL, Monteiro W, Moriera S, Morley A, Morrison L, Morriss R, Morrow A, Moss AJ, Moss P, Motohashi K, Msimanga N, Mukaetova-Ladinska E, Munawar U, Murira J, Nanda U, Nassa H, Nasseri M, Neal A, Needham R, Neill P, Newell H, Newman T, Newton-Cox A, Nicholson T, Nicoll D, Nolan CM, Noonan MJ, Norman C, Novotny P, Nunag J, Nwafor L, Nwanguma U, Nyaboko J, O'Donnell K, O'Brien C, O'Brien L, O'Regan D, Odell N, Ogg G, Olaosebikan O, Oliver C, Omar Z, Orriss-Dib L, Osborne L, Osbourne R, Ostermann M, Overton C, Owen J, Oxton J, Pack J, Pacpaco E, Paddick S, Painter S, Pakzad A, Palmer S, Papineni P, Paques K, Paradowski K, Pareek M, Parfrey H, Pariante C, Parker S, Parkes M, Parmar J, Patale S, Patel B, Patel M, Patel S, Pattenadk D, Pavlides M, Payne S, Pearce L, Pearl JE, Peckham D, Pendlebury J, Peng Y, Pennington C, Peralta I, Perkins E, Peterkin Z, Peto T, Petousi N, Petrie J, Phipps J, Pimm J, Piper Hanley K, Pius R, Plant H, Plein S, Plekhanova T, Plowright M, Polgar O, Poll L, Porter J, Portukhay S, Powell N, Prabhu A, Pratt J, Price A, Price C, Price C, Price D, Price L, Price L, Prickett A, Propescu J, Pugmire S, Quaid S, Quigley J, Qureshi H, Qureshi IN, Radhakrishnan K, Ralser M, Ramos A, Ramos H, Rangeley J, Rangelov B, Ratcliffe L, Ravencroft P, Reddington A, Reddy R, Redfearn H, Redwood D, Reed A, Rees M, Rees T, Regan K, Reynolds W, Ribeiro C, Richards A, Richardson E, Rivera-Ortega P, Roberts K, Robertson E, Robinson E, Robinson L, Roche L, Roddis C, Rodger J, Ross A, Ross G, Rossdale J, Rostron A, Rowe A, Rowland A, Rowland J, Roy K, Roy M, Rudan I, Russell R, Russell E, Saalmink G, Sabit R, Sage EK, Samakomva T, Samani N, Sampson C, Samuel K, Samuel R, Sanderson A, Sapey E, Saralaya D, Sargant J, Sarginson C, Sass T, Sattar N, Saunders K, Saunders P, Saunders LC, Savill H, Saxon W, Sayer A, Schronce J, Schwaeble W, Scott K, Selby N, Sewell TA, Shah K, Shah P, Shankar-Hari M, Sharma M, Sharpe C, Sharpe M, Shashaa S, Shaw A, Shaw K, Shaw V, Shelton S, Shenton L, Shevket K, Short J, Siddique S, Siddiqui S, Sidebottom J, Sigfrid L, Simons G, Simpson J, Simpson N, Singh C, Singh S, Sissons D, Skeemer J, Slack K, Smith A, Smith D, Smith S, Smith J, Smith L, Soares M, Solano TS, Solly R, Solstice AR, Soulsby T, Southern D, Sowter D, Spears M, Spencer LG, Speranza F, Stadon L, Stanel S, Steele N, Steiner M, Stensel D, Stephens G, Stephenson L, Stern M, Stewart I, Stimpson R, Stockdale S, Stockley J, Stoker W, Stone R, Storrar W, Storrie A, Storton K, Stringer E, Strong-Sheldrake S, Stroud N, Subbe C, Sudlow CL, Suleiman Z, Summers C, Summersgill C, Sutherland D, Sykes DL, Sykes R, Talbot N, Tan AL, Tarusan L, Tavoukjian V, Taylor A, Taylor C, Taylor J, Te A, Tedd H, Tee CJ, Teixeira J, Tench H, Terry S, Thackray-Nocera S, Thaivalappil F, Thamu B, Thickett D, Thomas C, Thomas S, Thomas AK, Thomas-Woods T, Thompson T, Thompson AAR, Thornton T, Tilley J, Tinker N, Tiongson GF, Tobin M, Tomlinson J, Tong C, Touyz R, Tripp KA, Tunnicliffe E, Turnbull A, Turner E, Turner S, Turner V, Turner K, Turney S, Turtle L, Turton H, Ugoji J, Ugwuoke R, Upthegrove R, Valabhji J, Ventura M, Vere J, Vickers C, Vinson B, Wade E, Wade P, Wainwright T, Wajero LO, Walder S, Walker S, Walker S, Wall E, Wallis T, Walmsley S, Walsh JA, Walsh S, Warburton L, Ward TJC, Warwick K, Wassall H, Waterson S, Watson E, Watson L, Watson J, Welch C, Welch H, Welsh B, Wessely S, West S, Weston H, Wheeler H, White S, Whitehead V, Whitney J, Whittaker S, Whittam B, Whitworth V, Wight A, Wild J, Wilkins M, Wilkinson D, Williams N, Williams N, Williams J, Williams-Howard SA, Willicombe M, Willis G, Willoughby J, Wilson A, Wilson D, Wilson I, Window N, Witham M, Wolf-Roberts R, Wood C, Woodhead F, Woods J, Wormleighton J, Worsley J, Wraith D, Wrey Brown C, Wright C, Wright L, Wright S, Wyles J, Wynter I, Xu M, Yasmin N, Yasmin S, Yates T, Yip KP, Young B, Young S, Young A, Yousuf AJ, Zawia A, Zeidan L, Zhao B, Zongo O. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med 2022; 10:761-775. [PMID: 35472304 PMCID: PMC9034855 DOI: 10.1016/s2213-2600(22)00127-8] [Citation(s) in RCA: 144] [Impact Index Per Article: 72.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/04/2022] [Revised: 03/23/2022] [Accepted: 03/31/2022] [Indexed: 11/25/2022]
Abstract
BACKGROUND No effective pharmacological or non-pharmacological interventions exist for patients with long COVID. We aimed to describe recovery 1 year after hospital discharge for COVID-19, identify factors associated with patient-perceived recovery, and identify potential therapeutic targets by describing the underlying inflammatory profiles of the previously described recovery clusters at 5 months after hospital discharge. METHODS The Post-hospitalisation COVID-19 study (PHOSP-COVID) is a prospective, longitudinal cohort study recruiting adults (aged ≥18 years) discharged from hospital with COVID-19 across the UK. Recovery was assessed using patient-reported outcome measures, physical performance, and organ function at 5 months and 1 year after hospital discharge, and stratified by both patient-perceived recovery and recovery cluster. Hierarchical logistic regression modelling was performed for patient-perceived recovery at 1 year. Cluster analysis was done using the clustering large applications k-medoids approach using clinical outcomes at 5 months. Inflammatory protein profiling was analysed from plasma at the 5-month visit. This study is registered on the ISRCTN Registry, ISRCTN10980107, and recruitment is ongoing. FINDINGS 2320 participants discharged from hospital between March 7, 2020, and April 18, 2021, were assessed at 5 months after discharge and 807 (32·7%) participants completed both the 5-month and 1-year visits. 279 (35·6%) of these 807 patients were women and 505 (64·4%) were men, with a mean age of 58·7 (SD 12·5) years, and 224 (27·8%) had received invasive mechanical ventilation (WHO class 7-9). The proportion of patients reporting full recovery was unchanged between 5 months (501 [25·5%] of 1965) and 1 year (232 [28·9%] of 804). Factors associated with being less likely to report full recovery at 1 year were female sex (odds ratio 0·68 [95% CI 0·46-0·99]), obesity (0·50 [0·34-0·74]) and invasive mechanical ventilation (0·42 [0·23-0·76]). Cluster analysis (n=1636) corroborated the previously reported four clusters: very severe, severe, moderate with cognitive impairment, and mild, relating to the severity of physical health, mental health, and cognitive impairment at 5 months. We found increased inflammatory mediators of tissue damage and repair in both the very severe and the moderate with cognitive impairment clusters compared with the mild cluster, including IL-6 concentration, which was increased in both comparisons (n=626 participants). We found a substantial deficit in median EQ-5D-5L utility index from before COVID-19 (retrospective assessment; 0·88 [IQR 0·74-1·00]), at 5 months (0·74 [0·64-0·88]) to 1 year (0·75 [0·62-0·88]), with minimal improvements across all outcome measures at 1 year after discharge in the whole cohort and within each of the four clusters. INTERPRETATION The sequelae of a hospital admission with COVID-19 were substantial 1 year after discharge across a range of health domains, with the minority in our cohort feeling fully recovered. Patient-perceived health-related quality of life was reduced at 1 year compared with before hospital admission. Systematic inflammation and obesity are potential treatable traits that warrant further investigation in clinical trials. FUNDING UK Research and Innovation and National Institute for Health Research.
Collapse
|
15
|
Ramoz N, Maussion G, Clarke J, Gorwood P. Genetic and epigenetic variations in BDNF gene involved in Anorexia Nervosa. Eur Psychiatry 2022. [PMCID: PMC9567959 DOI: 10.1192/j.eurpsy.2022.1743] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/04/2022] Open
Abstract
Introduction Anorexia nervosa (AN) is a chronic psychiatric disorder resulting from abnormal eating habits with a high prevalence (0.5%). AN involves genetic and epigenetic factors supporting that AN is a metabo-psychiatric disorder. One candidate gene for AN, validated by meta-analyzes, is BDNF which encodes the brain-derived neurotrophic factor. BDNF negatively modulates the central control of food intake and its injection in rodents induces weight loss and anorexia. In humans, we observed an association of its functional variant Val66Met/rs6265 and electrodermal response to images of thinness suggesting an association between rs6265 and a reward effect of weight loss in AN. Objectives This work study the impact of the functional polymorphism at risk rs6265, epigenetic variations in DNA methylation of BDNF gene and consequences on the concentrations of BDNF in AN patients. Methods DNA was isolated from 24 AN patients and 48 controls. DNA methylation was measured for sites spanning the BDNF gene using Infinium HumanMethylation450 BeadChip technology. The genotyping of rs6265 was performed by Taqman-SNP assay. The BDNF was dosaged by ELISA from plasmas. Results We observe that several sites are significantly hypermethylated in AN patients compared to controls. AN patients show significantly higher BDNF levels than controls. Finally, this BDNF concentration is significantly higher in AN carrying the risk Met66 allele. Conclusions This work demonstrates the effects of genetic and epigenetic variations of BDNF, which could constitute relevant diagnostic biomarkers of AN, and their likely consequences in the pathophysiology of AN. This work was supported by the Nestlé Foundation. Disclosure No significant relationships.
Collapse
|
16
|
Beaney T, Neves AL, Alboksmaty A, Ashrafian H, Flott K, Fowler A, Benger JR, Aylin P, Elkin S, Darzi A, Clarke J. Trends and associated factors for Covid-19 hospitalisation and fatality risk in 2.3 million adults in England. Nat Commun 2022; 13:2356. [PMID: 35487905 PMCID: PMC9054846 DOI: 10.1038/s41467-022-29880-7] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2021] [Accepted: 04/04/2022] [Indexed: 11/18/2022] Open
Abstract
The Covid-19 mortality rate varies between countries and over time but the extent to which this is explained by the underlying risk in those infected is unclear. Using data on all adults in England with a positive Covid-19 test between 1st October 2020 and 30th April 2021 linked to clinical records, we examined trends and risk factors for hospital admission and mortality. Of 2,311,282 people included in the study, 164,046 (7.1%) were admitted and 53,156 (2.3%) died within 28 days of a positive Covid-19 test. We found significant variation in the case hospitalisation and mortality risk over time, which remained after accounting for the underlying risk of those infected. Older age groups, males, those resident in areas of greater socioeconomic deprivation, and those with obesity had higher odds of admission and death. People with severe mental illness and learning disability had the highest odds of admission and death. Our findings highlight both the role of external factors in Covid-19 admission and mortality risk and the need for more proactive care in the most vulnerable groups.
Collapse
Affiliation(s)
- T Beaney
- Patient Safety Translational Research Centre, Institute of Global Health Innovation, Imperial College London, London, SW7 2AZ, UK.
- Department of Primary Care and Public Health, Imperial College London, London, W6 8RP, UK.
| | - A L Neves
- Patient Safety Translational Research Centre, Institute of Global Health Innovation, Imperial College London, London, SW7 2AZ, UK
| | - A Alboksmaty
- Patient Safety Translational Research Centre, Institute of Global Health Innovation, Imperial College London, London, SW7 2AZ, UK
- Department of Primary Care and Public Health, Imperial College London, London, W6 8RP, UK
| | - H Ashrafian
- Patient Safety Translational Research Centre, Institute of Global Health Innovation, Imperial College London, London, SW7 2AZ, UK
| | - K Flott
- Patient Safety Translational Research Centre, Institute of Global Health Innovation, Imperial College London, London, SW7 2AZ, UK
| | - A Fowler
- NHS England and Improvement, London, SE1 6LH, UK
| | - J R Benger
- NHS Digital, 7-8 Wellington Place, Leeds, West Yorkshire, LS1 4AP, UK
| | - P Aylin
- Patient Safety Translational Research Centre, Institute of Global Health Innovation, Imperial College London, London, SW7 2AZ, UK
- Department of Primary Care and Public Health, Imperial College London, London, W6 8RP, UK
| | - S Elkin
- National Heart and Lung Institute, Imperial College London, London, SW7 2AZ, UK
| | - A Darzi
- Patient Safety Translational Research Centre, Institute of Global Health Innovation, Imperial College London, London, SW7 2AZ, UK
| | - J Clarke
- Patient Safety Translational Research Centre, Institute of Global Health Innovation, Imperial College London, London, SW7 2AZ, UK
- Centre for Mathematics of Precision Healthcare, Department of Mathematics, Imperial College London, London, SW7 2AZ, UK
| |
Collapse
|
17
|
Gujjuri R, Clarke J, Elliot J, Reynolds J, Markar S. 36 Predicting Long-Term Survival and Time-to-Recurrence After Oesophagectomy in Patients with Oesophageal Cancer. Br J Surg 2022. [DOI: 10.1093/bjs/znac041.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Abstract
Aim
Long-term survival after oesophagectomy remains poor, with recurrence a feared common outcome. Prediction tools can identify high-risk patients and optimise treatment decisions based on their prognostic factors. This study developed a prediction model to predict long-term survival and time-to-recurrence following surgery for oesophageal cancer.
Method
Patients undergoing curative surgery from the European iNvestigation of SUrveillance After Resection for Esophageal Cancer study were included. Prediction models were developed for overall survival (OS) and disease-free survival (DFS) using Cox proportional hazards (CPH) and Random Survival Forest (RSF). Model performance was evaluated using discrimination (time-dependent area under the curve (tAUC)) and calibration (visual comparison of predicted and observed survival probabilities).
Results
This study included 4719 patients with an OS of 47.7% and DFS of 48.4% at 5 years. Sixteen variables were included. CPH and RSF demonstrated good discrimination with a tAUC of 78.2% (95% CI 77.4–79.1%) and 77.1% (95% CI 76.1–78.1%) for OS and a tAUC of 79.4% (95% CI 78.5–80.2%) and 78.6% (95% CI 77.5–79.5%) respectively for DFS at 5 years. CPH showed good agreement between predicted and observed probabilities in all quintiles. RSF showed good agreement for patients with survival probabilities between 20–80%.
Conclusions
This study demonstrated that a statistical model can accurately predict long-term survival and time-to-recurrence after oesophagectomy. Identification of patient groups at risk of recurrence and poor long-term survival can improve patient outcomes by optimising treatment methods and surveillance strategies. Future work evaluating prediction-based decisions against standard decision-making is required to understand the clinical utility derived from prognostic model use.
Collapse
Affiliation(s)
- R. Gujjuri
- College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom
| | - J. Clarke
- Centre for Mathematics of Precision Healthcare, Department of Mathematics, Imperial College London, London, United Kingdom
| | - J. Elliot
- Trinity St. James’s Cancer Institute, St. James’s Hospital, Dublin, Ireland
| | - J. Reynolds
- Trinity St. James’s Cancer Institute, St. James’s Hospital, Dublin, Ireland
| | - S. Markar
- Imperial College London, Department of Surgery and Cancer, St Mary’s Hospital Campus, London, United Kingdom
| | | |
Collapse
|
18
|
Gujjuri R, Clarke J, Elliot J, Reynolds J, Markar S. 36 Predicting Long-Term Survival and Time-to-Recurrence After Oesophagectomy in Patients with Oesophageal Cancer. Br J Surg 2022. [DOI: 10.1093/bjs/znac041.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Abstract
Aim
Long-term survival after oesophagectomy remains poor, with recurrence a feared common outcome. Prediction tools can identify high-risk patients and optimise treatment decisions based on their prognostic factors. This study developed a prediction model to predict long-term survival and time-to-recurrence following surgery for oesophageal cancer.
Method
Patients undergoing curative surgery from the European iNvestigation of SUrveillance After Resection for Esophageal Cancer study were included. Prediction models were developed for overall survival (OS) and disease-free survival (DFS) using Cox proportional hazards (CPH) and Random Survival Forest (RSF). Model performance was evaluated using discrimination (time-dependent area under the curve (tAUC)) and calibration (visual comparison of predicted and observed survival probabilities).
Results
This study included 4719 patients with an OS of 47.7% and DFS of 48.4% at 5 years. Sixteen variables were included. CPH and RSF demonstrated good discrimination with a tAUC of 78.2% (95% CI 77.4–79.1%) and 77.1% (95% CI 76.1–78.1%) for OS and a tAUC of 79.4% (95% CI 78.5–80.2%) and 78.6% (95% CI 77.5–79.5%) respectively for DFS at 5 years. CPH showed good agreement between predicted and observed probabilities in all quintiles. RSF showed good agreement for patients with survival probabilities between 20–80%.
Conclusions
This study demonstrated that a statistical model can accurately predict long-term survival and time-to-recurrence after oesophagectomy. Identification of patient groups at risk of recurrence and poor long-term survival can improve patient outcomes by optimising treatment methods and surveillance strategies. Future work evaluating prediction-based decisions against standard decision-making is required to understand the clinical utility derived from prognostic model use.
Collapse
Affiliation(s)
- R. Gujjuri
- College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom
| | - J. Clarke
- Centre for Mathematics of Precision Healthcare, Department of Mathematics, Imperial College London, London, United Kingdom
| | - J. Elliot
- Trinity St. James’s Cancer Institute, St. James’s Hospital, Dublin, Ireland
| | - J. Reynolds
- Trinity St. James’s Cancer Institute, St. James’s Hospital, Dublin, Ireland
| | - S. Markar
- Imperial College London, Department of Surgery and Cancer, St Mary’s Hospital Campus, London, United Kingdom
| | | |
Collapse
|
19
|
Enzian G, Freisem L, Price JJ, Svela AØ, Clarke J, Shajilal B, Janousek J, Buchler BC, Lam PK, Vanner MR. Non-Gaussian Mechanical Motion via Single and Multiphonon Subtraction from a Thermal State. Phys Rev Lett 2021; 127:243601. [PMID: 34951800 DOI: 10.1103/physrevlett.127.243601] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/08/2021] [Accepted: 11/08/2021] [Indexed: 06/14/2023]
Abstract
Quantum optical measurement techniques offer a rich avenue for quantum control of mechanical oscillators via cavity optomechanics. In particular, a powerful yet little explored combination utilizes optical measurements to perform heralded non-Gaussian mechanical state preparation followed by tomography to determine the mechanical phase-space distribution. Here, we experimentally perform heralded single-phonon and multiphonon subtraction via photon counting to a laser-cooled mechanical thermal state with a Brillouin optomechanical system at room temperature and use optical heterodyne detection to measure the s-parametrized Wigner distribution of the non-Gaussian mechanical states generated. The techniques developed here advance the state of the art for optics-based tomography of mechanical states and will be useful for a broad range of applied and fundamental studies that utilize mechanical quantum-state engineering and tomography.
Collapse
Affiliation(s)
- G Enzian
- QOLS, Blackett Laboratory, Imperial College London, London SW7 2BW, United Kingdom
- Clarendon Laboratory, Department of Physics, University of Oxford, Oxford OX1 3PU, United Kingdom
- Niels Bohr Institute, University of Copenhagen, Copenhagen 2100, Denmark
| | - L Freisem
- QOLS, Blackett Laboratory, Imperial College London, London SW7 2BW, United Kingdom
- Clarendon Laboratory, Department of Physics, University of Oxford, Oxford OX1 3PU, United Kingdom
| | - J J Price
- QOLS, Blackett Laboratory, Imperial College London, London SW7 2BW, United Kingdom
- Clarendon Laboratory, Department of Physics, University of Oxford, Oxford OX1 3PU, United Kingdom
| | - A Ø Svela
- QOLS, Blackett Laboratory, Imperial College London, London SW7 2BW, United Kingdom
- Clarendon Laboratory, Department of Physics, University of Oxford, Oxford OX1 3PU, United Kingdom
- Max Planck Institute for the Science of Light, Staudtstaße 2, 91058 Erlangen, Germany
| | - J Clarke
- QOLS, Blackett Laboratory, Imperial College London, London SW7 2BW, United Kingdom
| | - B Shajilal
- Centre for Quantum Computation and Communication Technology, Research School of Physics and Engineering, Australian National University, Canberra 2601, Australia
| | - J Janousek
- Centre for Quantum Computation and Communication Technology, Research School of Physics and Engineering, Australian National University, Canberra 2601, Australia
| | - B C Buchler
- Centre for Quantum Computation and Communication Technology, Research School of Physics and Engineering, Australian National University, Canberra 2601, Australia
| | - P K Lam
- Centre for Quantum Computation and Communication Technology, Research School of Physics and Engineering, Australian National University, Canberra 2601, Australia
| | - M R Vanner
- QOLS, Blackett Laboratory, Imperial College London, London SW7 2BW, United Kingdom
- Clarendon Laboratory, Department of Physics, University of Oxford, Oxford OX1 3PU, United Kingdom
| |
Collapse
|
20
|
Taasan S, Wolf S, Wang X, Antonia S, Crawford J, Ready N, Stinchcombe T, Clarke J. P27.04 Clinical Outcomes for Patients With Stage III NSCLC and STK11 or KEAP1 Genetic Alterations. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.08.387] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
21
|
Salton M, Carr M, Tarjan LM, Clarke J, Kirkwood R, Slip D, Harcourt R. Protected area use by two sympatric marine predators repopulating their historical range. ENDANGER SPECIES RES 2021. [DOI: 10.3354/esr01129] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
As large carnivores recover from over-exploitation, managers often lack evidence-based information on species habitat requirements and the efficacy of management practices, particularly where species repopulate areas from which they have long been extirpated. We investigated the movement and habitat use by 2 semi-aquatic carnivores (Australian fur seals Arctocephalus pusillus doriferus and New Zealand fur seals A. forsteri) at the northern end of their distributions in Australia, where after a long absence both are recolonising their historic range. We also assessed male fur seal habitat use overlap with terrestrial and marine protected areas (PAs). While at the margin of the range during winter and early spring, the males remained inshore close to terrestrial sites and where interactions with humans often occur. From early spring, the males from the range margin showed uniform movement toward colonies in the core of the species’ range prior to their breeding seasons. This contrasts with males tracked from the core of the species’ range that returned periodically to colonies during the year, and highlights the importance of range-wide monitoring of a species to inform conservation planning. Habitat use by some males included over 90% of a marine PA at the margin of the species’ range. Most terrestrial haul-outs used were within terrestrial PAs, while sites not protected were on the margin of the range. Despite wide-ranging habits, their dependence on coastal sites, where human access and activities can be regulated and more readily enforced, suggests that terrestrial and marine PAs will continue to play an important role in managing the recovery of these fur seals.
Collapse
Affiliation(s)
- M Salton
- Department of Biological Sciences, Macquarie University, North Ryde, New South Wales 2109, Australia
- Australian Antarctic Division, Department of Agriculture, Water and Environment, Kingston, Tasmania 7050, Australia
| | - M Carr
- Department of Primary Industries, Jervis Bay Marine Park, New South Wales 2540, Australia
- Biodiversity Conservation Trust, Coffs Harbour, New South Wales 2450, Australia
| | - LM Tarjan
- Department of Ecology and Evolutionary Biology, University of California, Santa Cruz, California 95064, USA
- San Francisco Bay Bird Observatory, 524 Valley Way, Milpitas, California 95035, USA
| | - J Clarke
- Department of Biological Sciences, Macquarie University, North Ryde, New South Wales 2109, Australia
| | - R Kirkwood
- Research Department, Phillip Island Nature Parks, Cowes, Victoria 3922, Australia
- SARDI Aquatic Sciences, West Beach, South Australia 5024, Australia
| | - D Slip
- Department of Biological Sciences, Macquarie University, North Ryde, New South Wales 2109, Australia
- Taronga Conservation Society Australia, Mosman, New South Wales 2088, Australia
| | - R Harcourt
- Department of Biological Sciences, Macquarie University, North Ryde, New South Wales 2109, Australia
| |
Collapse
|
22
|
Ghanem YKM, Clarke J, Jacob T, Ahmad NZ. 157 A Rare Case of Cutaneous-Urachovesicoenteric Fistula in a Patient with Crohn’s Disease. Br J Surg 2021. [DOI: 10.1093/bjs/znab134.236] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Abstract
Background
Entero-Uracho Vesicle fistulae are a rare sequelae of aggressive Crohn’s disease with only a small number of case reports being available in the literature. Such cases are most often managed via “SSNAP” principles with many Crohn’s fistulas requiring complex surgical intervention to definitively deal with the offending fistulous tracts. We present a case with an even rarer consequence of uncontrolled Crohn’s disease despite immunomodulatory therapy in a 34-year-old male who presented with a Entero-Uracho Vesicle fistula. We discuss the presenting symptoms and management protocol involved in this case.
Case:
A 34-year-old male with known Crohn’s disease presented with an entero-uracho vesicle fistula, which further developed into a cutenaous-urachovesicoenteric fistula while awaiting surgery during his index admission. The fistula tract was confirmed via Computed Tomography with evidence of significant inflammation. Bowel rest, antibiotics, and nutritional support with Total Parenteral Nutrition preceded total excision of the fistulous tract with ileo-caecal resection of the diseased bowel with primary anastomosis, and resection of the urachus and closure of the cutaneous fistula site with desirable outcome. Patient completed a full-recovery with return of normal bowel function and nutritional status, with no delayed complications at 6-month follow-up.
Collapse
Affiliation(s)
| | - J Clarke
- University Hospital Limerick, Limerick, Ireland
| | - T Jacob
- University Hospital Limerick, Limerick, Ireland
| | - N Z Ahmad
- University Hospital Limerick, Limerick, Ireland
| |
Collapse
|
23
|
Hadadi I, Rae W, Clarke J, McEntee M, Ekpo E. Breast cancer detection: Comparison of digital mammography and digital breast tomosynthesis across non-dense and dense breasts. Radiography (Lond) 2021; 27:1027-1032. [PMID: 33906803 DOI: 10.1016/j.radi.2021.04.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2021] [Revised: 03/24/2021] [Accepted: 04/07/2021] [Indexed: 10/21/2022]
Abstract
INTRODUCTION Breast density is associated with an increase in breast cancer risk and limits early detection of the disease. This study assesses the diagnostic performance of mammogram readers in digital mammography (DM) and digital breast tomosynthesis (DBT). METHODS Eleven breast readers with 1-39 years of experience reading mammograms and 0-4 years of experience reading DBT participated in the study. All readers independently interpreted 60 DM cases (40 normal/20 abnormal) and 35 DBT cases (20 normal/15 abnormal). Sensitivity, specificity, ROC AUC, and diagnostic confidence were calculated and compared between DM and DBT. RESULTS DBT significantly improved diagnostic confidence in both dense breasts (p = 0.03) and non-dense breasts (p = 0.003) but not in other diagnostic performance metrics. Specificity was higher in DM for readers with >7 years' experience (p = 0.03) in reading mammography, non-radiologists (p = 0.04), readers who had completed a 3-6 months training fellowship in breast imaging (p = 0.04), and those with ≤2 years' experience in reading DBT (p = 0.02), particularly in non-dense breasts. CONCLUSION Diagnostic confidence was higher in DBT when compared to DM. In contrast, other performance metrics appeared to be similar or better with DM and may be influenced by the lack of experience of the reader cohort in reading DBT. IMPLICATIONS FOR PRACTICE The benefits of DBT may not be entirely accrued until radiologists attain expertise in DBT interpretation. Specificity of DBT varied according to reader characteristics, and these characteristics may be useful for optimising pairing strategies in independent double reading of DBT as practiced in Australia to reduce false positive diagnostic errors.
Collapse
Affiliation(s)
- I Hadadi
- Medical Image Optimisation and Perception Group, Discipline of Medical Imaging Science, Faculty of Medicine and Health, The University of Sydney, Australia; Department of Radiological Sciences, Faculty of Applied Medical Sciences, King Khalid University, Saudi Arabia.
| | - W Rae
- Medical Image Optimisation and Perception Group, Discipline of Medical Imaging Science, Faculty of Medicine and Health, The University of Sydney, Australia
| | - J Clarke
- Medical Image Optimisation and Perception Group, Discipline of Medical Imaging Science, Faculty of Medicine and Health, The University of Sydney, Australia
| | - M McEntee
- Medical Image Optimisation and Perception Group, Discipline of Medical Imaging Science, Faculty of Medicine and Health, The University of Sydney, Australia; University College Cork, Discipline of Diagnostic Radiography, UG 12 Áras Watson, Brookfield Health Sciences, College Road, Cork, T12 AK54, Ireland
| | - E Ekpo
- Medical Image Optimisation and Perception Group, Discipline of Medical Imaging Science, Faculty of Medicine and Health, The University of Sydney, Australia; Orange Radiology, Laboratories and Research Centre, Calabar, Nigeria
| |
Collapse
|
24
|
Sacher A, Le X, Cornelissen R, Shum E, Suga J, Socinski M, Molina J, Haura E, Clarke J, Bhat G, Lebel F, Garassino M. 36MO Safety, tolerability and preliminary efficacy of poziotinib with twice daily strategy in EGFR/HER2 Exon 20 mutant non-small cell lung cancer. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.01.051] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
25
|
Tranquille C, Clarke J, Walker V, Murray R. A descriptive study quantifying warm-up patterns in elite and non-elite dressage horses in a field environment. Comparative Exercise Physiology 2021. [DOI: 10.3920/cep200032] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
There is very little reported information on the content of the warm-up period in dressage horses. Our objective was to quantify warm-up content, patterns and duration in a simulated competition (field) environment in British dressage horses. Twelve elite (Group A) and 20 non-elite (Group B) mixed-breed dressage horses, all ridden by advanced level riders, were assessed. Riders warmed-up as they would normally for a competition prior to completing a test. The warm-up was videoed and assessed retrospectively. Total duration, time spent in the different paces, and on which rein, was recorded, along with information on which movements were performed, and the head and neck position. Appropriate statistical tests were used to compare variables between groups. Mean warm-up duration, time in walk and trot did not differ between groups, however Group A horses spent significantly more time in canter than Group B horses (P=0.0024). Group A horses also spent significantly more time in collected and extended paces, and performing advanced movements than Group B horses (P≤0.0421 for all variables). There was no difference in time spent on the left and right rein in either group. Results provide novel information on the warm-up content in a competition (field) environment for dressage horses. The findings indicate that that the content of the warm-up of elite and non-elite dressage horses was significantly different, with elite horses warming up for longer, spending more time in canter, performing more changes within paces and advanced movements. Dressage horses appear to warm-up more symmetrically than has been reported in jumping horses.
Collapse
Affiliation(s)
- C.A. Tranquille
- Animal Health Trust, Lanwades Park, Newmarket, Suffolk CB8 7UU, United Kingdom
- Hartpury University, Hartpury, Gloucestershire GL19 3BE, United Kingdom
| | - J. Clarke
- Animal Health Trust, Lanwades Park, Newmarket, Suffolk CB8 7UU, United Kingdom
- Scottgate Close 11, Great Hockham, IP24 1PS, United Kingdom
| | - V.A. Walker
- Animal Health Trust, Lanwades Park, Newmarket, Suffolk CB8 7UU, United Kingdom
- Brick Works Cottages 3, Factory Road, Burwell CB25 0BN, United Kingdom
| | - R.C. Murray
- Animal Health Trust, Lanwades Park, Newmarket, Suffolk CB8 7UU, United Kingdom
- VetCT, St John’s Innovation Centre, Cowley Road, Cambridge, CB4 0WS, United Kingdom
| |
Collapse
|
26
|
Socinski M, Cornelissen R, Garassino M, Clarke J, Tchekmedyian N, Molina J, Goldman J, Bhat G, Lebel F, Le X. LBA60 ZENITH20, a multinational, multi-cohort phase II study of poziotinib in NSCLC patients with EGFR or HER2 exon 20 insertion mutations. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.2293] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
27
|
Jugmohansingh G, Peng H, Clarke J. Endoscopic endonasal repair of a cerebrospinal fluid leak secondary to a meningoencephalocele using a posterior – based middle turbinate flap. Caribb Med J 2020. [DOI: 10.48107/cmj.2020.08.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Cerebrospinal fluid leaks are rare but remain an important differential diagnosis for patients presenting with persistent, unilateral rhinorrhoea. This case describes a middle-aged female with persistent left sided rhinorrhea. She was minimally responsive to treatment for chronic sinusitis. On re-evaluation, a cerebrospinal fluid leak secondary to a meningoencephalocele was identified. This was subsequently repaired with a pedicled, vascularized graft using an endoscopic endonasal approach. The discussion which follows reviews the management of CSF rhinorrhoea with an emphasis on the available surgical options as well as the materials used for repair.
Collapse
Affiliation(s)
- G Jugmohansingh
- Department of Otolaryngology, San Fernando General Hospital, Trinidad and Tobago, West Indies
| | - H Peng
- Department of Otolaryngology, San Fernando General Hospital, Trinidad and Tobago, West Indies
| | - J Clarke
- Department of Otolaryngology, San Fernando General Hospital, Trinidad and Tobago, West Indies
| |
Collapse
|
28
|
Clarke J, Beaney T, Majeed A, Darzi A, Barahona M. METHODS RESEARCH. Health Serv Res 2020. [DOI: 10.1111/1475-6773.13483] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
Affiliation(s)
- J. Clarke
- Centre for Health Policy Institute of Global Health Innovation Imperial College London London United Kingdom
| | - T. Beaney
- Imperial College London London United Kingdom
| | - A. Majeed
- Department of Primary Care Imperial College London London United Kingdom
| | - A. Darzi
- Institute of Global Health Innovation Imperial College London London United Kingdom
| | - M. Barahona
- Centre for Mathematics of Precision Healthcare Imperial College London London United Kingdom
| |
Collapse
|
29
|
Warren L, Clarke J, Darzi A. Measuring the Scale of Hospital Health Record System Fragmentation in England. Health Serv Res 2020. [DOI: 10.1111/1475-6773.13386] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
Affiliation(s)
- L. Warren
- Patient Safety Translational Research Centre Imperial College London London United Kingdom
| | - J. Clarke
- Centre for Health Policy Institute of Global Health Innovation Imperial College London London United Kingdom
| | - A. Darzi
- Institute of Global Health Innovation Imperial College London London United Kingdom
| |
Collapse
|
30
|
Clarke J, Ali E, Hopkins P. Do in vitro pharmacological challenge responses differ between muscle specimens from malignant hyperthermia probands and their susceptible relatives? Br J Anaesth 2020. [DOI: 10.1016/j.bja.2019.11.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
31
|
Podboy A, Clarke J, Nguyen L, Mooney J, Dhillon G, Hwang J. Outcomes of Gastric Per-Oral Endoscopic Pyloromyotomy for Severe Gastroparesis in a Lung Transplant Patient Population. J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.714] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
32
|
Braine T, Cervantes R, Crisosto N, Du N, Kimes S, Rosenberg LJ, Rybka G, Yang J, Bowring D, Chou AS, Khatiwada R, Sonnenschein A, Wester W, Carosi G, Woollett N, Duffy LD, Bradley R, Boutan C, Jones M, LaRoque BH, Oblath NS, Taubman MS, Clarke J, Dove A, Eddins A, O'Kelley SR, Nawaz S, Siddiqi I, Stevenson N, Agrawal A, Dixit AV, Gleason JR, Jois S, Sikivie P, Solomon JA, Sullivan NS, Tanner DB, Lentz E, Daw EJ, Buckley JH, Harrington PM, Henriksen EA, Murch KW. Extended Search for the Invisible Axion with the Axion Dark Matter Experiment. Phys Rev Lett 2020; 124:101303. [PMID: 32216421 DOI: 10.1103/physrevlett.124.101303] [Citation(s) in RCA: 63] [Impact Index Per Article: 15.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/30/2019] [Revised: 01/23/2020] [Accepted: 02/18/2020] [Indexed: 06/10/2023]
Abstract
This Letter reports on a cavity haloscope search for dark matter axions in the Galactic halo in the mass range 2.81-3.31 μeV. This search utilizes the combination of a low-noise Josephson parametric amplifier and a large-cavity haloscope to achieve unprecedented sensitivity across this mass range. This search excludes the full range of axion-photon coupling values predicted in benchmark models of the invisible axion that solve the strong CP problem of quantum chromodynamics.
Collapse
Affiliation(s)
- T Braine
- University of Washington, Seattle, Washington 98195, USA
| | - R Cervantes
- University of Washington, Seattle, Washington 98195, USA
| | - N Crisosto
- University of Washington, Seattle, Washington 98195, USA
| | - N Du
- University of Washington, Seattle, Washington 98195, USA
| | - S Kimes
- University of Washington, Seattle, Washington 98195, USA
| | - L J Rosenberg
- University of Washington, Seattle, Washington 98195, USA
| | - G Rybka
- University of Washington, Seattle, Washington 98195, USA
| | - J Yang
- University of Washington, Seattle, Washington 98195, USA
| | - D Bowring
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A S Chou
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - R Khatiwada
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Sonnenschein
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - W Wester
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Carosi
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - N Woollett
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - L D Duffy
- Los Alamos National Laboratory, Los Alamos, California 87545, USA
| | - R Bradley
- National Radio Astronomy Observatory, Charlottesville, Virginia 22903, USA
| | - C Boutan
- Pacific Northwest National Laboratory, Richland, Washington 99354, USA
| | - M Jones
- Pacific Northwest National Laboratory, Richland, Washington 99354, USA
| | - B H LaRoque
- Pacific Northwest National Laboratory, Richland, Washington 99354, USA
| | - N S Oblath
- Pacific Northwest National Laboratory, Richland, Washington 99354, USA
| | - M S Taubman
- Pacific Northwest National Laboratory, Richland, Washington 99354, USA
| | - J Clarke
- University of California, Berkeley, California 94720, USA
| | - A Dove
- University of California, Berkeley, California 94720, USA
| | - A Eddins
- University of California, Berkeley, California 94720, USA
| | - S R O'Kelley
- University of California, Berkeley, California 94720, USA
| | - S Nawaz
- University of California, Berkeley, California 94720, USA
| | - I Siddiqi
- University of California, Berkeley, California 94720, USA
| | - N Stevenson
- University of California, Berkeley, California 94720, USA
| | - A Agrawal
- University of Chicago, Chicago, Illinois 60637, USA
| | - A V Dixit
- University of Chicago, Chicago, Illinois 60637, USA
| | - J R Gleason
- University of Florida, Gainesville, Florida 32611, USA
| | - S Jois
- University of Florida, Gainesville, Florida 32611, USA
| | - P Sikivie
- University of Florida, Gainesville, Florida 32611, USA
| | - J A Solomon
- University of Florida, Gainesville, Florida 32611, USA
| | - N S Sullivan
- University of Florida, Gainesville, Florida 32611, USA
| | - D B Tanner
- University of Florida, Gainesville, Florida 32611, USA
| | - E Lentz
- University of Göttingen, Göttingen 37077, Germany
| | - E J Daw
- University of Sheffield, Sheffield S3 7RH, United Kingdom
| | - J H Buckley
- Washington University, St. Louis, Missouri 63130, USA
| | | | - E A Henriksen
- Washington University, St. Louis, Missouri 63130, USA
| | - K W Murch
- Washington University, St. Louis, Missouri 63130, USA
| |
Collapse
|
33
|
Feldsine PT, Falbo-Nelson MT, Hustead DL, Aaronson J, Arling V, Baker M, Bozzuffi J, Bremer N, Chlebowski E, Clarke J, Crane A, Daniell E, Daugherty N, David J, Davis T, Diaz R, Donnelly S, Elwood M, Forgey R, Freshley J, Glowka L, Gottshall R, Graham R, Gray M, Griffith M, Hansen M, Harmon T, Herman R, Hofstrand P, Huether K, Irbys S, Jackey B, Jackson J, Jones T, Khasmakhi A, Lifur L, Linger T, MaCeda J, Mackin M, Marone C, McClure A, McDonagh S, Milligan L, Nelson J, Pandit K, Poole S, Rizzo M, Robinson J, Sparano R, Schriver J, Seibert M, Stone J, Summers D, Sweger L, Tebay D, Vera G, Weaver A, Wempe J, Wilkinson C, Willett J, Willoughby S, Zook T. Substrate Supporting Disc Method for Confirmed Detection of Total Coliforms and E. coli in all Foods: Collaborative Study. J AOAC Int 2020. [DOI: 10.1093/jaoac/76.5.988] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
Abstract
The Coli Complete® substrate supporting disc (SSD) method for simultaneous confirmed total coliform count and Escherichia coli determination in all foods was compared with AOAC most probable number (MPN) methods, 966.23 and 966.24. Twenty-nine laboratories participated in this collaborative study in which 6 food types were analyzed. Four food types, raw ground beef, pork sausage, raw liquid milk, and nut meats, were naturally contaminated with coliform bacteria. Two foods, dry egg and fresh frozen vegetables, were seeded with coliforms. Three food types, ground beef, raw liquid milk, and pork sausage, were naturally contaminated with E. coli. Although pork sausage was naturally contaminated, the level was very low (<10/50 g); therefore, additional E. coli were inoculated into 1 lot of this food type. Three food types, nut meats, dry egg, and fresh frozen vegetables, were inoculated with E. coli. For naturally contaminated samples, duplicate determinations were made on 3 separate lots for each food type. For inoculated samples, low, medium, and high contamination levels plus uninoculated control samples were examined in duplicate. Data were analyzed separately for total coliform bacteria and for E. coli. Mean log MPN counts were determined by the SSD method and the appropriate AOAC MPN method. Results were then analyzed for repeatability, reproducibility, and mean log MPN statistical equivalence. Results were statistically equivalent for all total coliform levels in all food types except frozen vegetable and raw nut meat uninoculated control samples and 1 lot of pork sausage where the SSD method produced statistically significant greater numbers. For the E. coli determinations, results were statistically equivalent across all samples and all levels for each food type. The SSD method has been adopted first action by AOAC International for confirmed detection of total coliforms and E. coli in all foods.
Collapse
Affiliation(s)
- Philip T Feldsine
- BioControl Systems, Inc., 19805 North Creek Parkway, Bothell, WA 98011
| | | | - David L Hustead
- BioControl Systems, Inc., 19805 North Creek Parkway, Bothell, WA 98011
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
34
|
Reckamp K, Akerley W, Calvo E, Clarke J, Edelman M, He K, Moreno V, Neal J, Owonikoko T, Patel J, Patel S, Riess J, Sacher A, Turcotte S, Villaruz L, Zauderer M, Farsaci B, Skoura N, Chisamore M, Johnson M. Safety, tolerability and activity of autologous T-cells with enhanced T-cell receptors specific to NY ESO 1/LAGE 1a (GSK3377794) alone, or in combination with pembrolizumab, in advanced non-small cell lung cancer: A phase Ib/IIa randomised pilot study. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz260.112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
35
|
Van Tine B, Butler M, Araujo D, Johnson M, Clarke J, Liebner D, Odunsi K, Olszanski A, Basu S, Brophy F, Holdich T, Trivedi T, Amado R, Hong D. ADP-A2M4 (MAGE-A4) in patients with synovial sarcoma. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz283.003] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
36
|
Ready N, Tong B, Clarke J, Gu L, Wigle D, Dragnev K, Sporn T, Stinchcombe T, D’Amico T. P2.04-89 Neoadjuvant Pembrolizumab in Early Stage Non-Small Cell Lung Cancer (NSCLC): Toxicity, Efficacy, and Surgical Outcomes. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1594] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
37
|
Dehnhard N, Achurch H, Clarke J, Michel LN, Southwell C, Sumner MD, Eens M, Emmerson L. High inter‐ and intraspecific niche overlap among three sympatrically breeding, closely related seabird species: Generalist foraging as an adaptation to a highly variable environment? J Anim Ecol 2019; 89:104-119. [DOI: 10.1111/1365-2656.13078] [Citation(s) in RCA: 32] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2018] [Accepted: 05/16/2019] [Indexed: 02/02/2023]
Affiliation(s)
- Nina Dehnhard
- Department of Biology, Behavioural Ecology and Ecophysiology Group University of Antwerp Antwerp (Wilrijk) Belgium
- Australian Antarctic Division, Department of the Environment and Energy Kingston Tas. Australia
- Norwegian Institute for Nature Research – NINA Trondheim Norway
| | - Helen Achurch
- Australian Antarctic Division, Department of the Environment and Energy Kingston Tas. Australia
| | - Judy Clarke
- Australian Antarctic Division, Department of the Environment and Energy Kingston Tas. Australia
| | - Loïc N. Michel
- Freshwater and Oceanic Sciences Unit of reSearch (FOCUS), Laboratory of Oceanology University of Liège Liège Belgium
| | - Colin Southwell
- Australian Antarctic Division, Department of the Environment and Energy Kingston Tas. Australia
| | - Michael D. Sumner
- Australian Antarctic Division, Department of the Environment and Energy Kingston Tas. Australia
| | - Marcel Eens
- Department of Biology, Behavioural Ecology and Ecophysiology Group University of Antwerp Antwerp (Wilrijk) Belgium
| | - Louise Emmerson
- Australian Antarctic Division, Department of the Environment and Energy Kingston Tas. Australia
| |
Collapse
|
38
|
Price J, Shantzer L, Jacobs C, Niedzwiecki D, Clarke J, Kelsey C, Salama J, Torok J. Radiation Therapy Prior to Immune Checkpoint Inhibition in Metastatic Non-Small Cell Lung Cancer: Determining Toxicity and Efficacy of Combination Treatment. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.2429] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
39
|
Russell T, Lane A, Clarke J, Hogg C, Morris K, Keeley T, Madsen T, Ujvari B. Multiple paternity and precocial breeding in wild Tasmanian devils, Sarcophilus harrisii (Marsupialia: Dasyuridae). Biol J Linn Soc Lond 2019. [DOI: 10.1093/biolinnean/blz072] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Abstract
Polyandry, a common reproductive strategy in various animal species, has potential female benefits, which include enhanced offspring fitness. Benefits can be direct, such as reduced risk of male infanticide of offspring, or indirect, such as increased genetic diversity of offspring and the acquisition of ‘good genes’. Multiple paternity of litters has been recorded in numerous marsupial species but has not been reported in Tasmanian devils, Sarcophilus harrisii (Boitard). We investigated whether multiple paternity occurred in litters within a wild population of Tasmanian devils. Using major histocompatibility complex-linked and neutral microsatellite markers, the paternity of nine litters was analysed. We found multiple paternity in four out of nine litters and that yearling (> 1, < 2 years old) male devils were siring offspring. This is the first record of multiple paternity and of male precocial breeding in wild Tasmanian devils. To date, there are no data relating to the subsequent survival of devils from single- vs. multiple-sired litters; therefore, we do not know whether multiple paternity increases offspring survival in the wild. These results have implications for the Tasmanian devil captive insurance programme, because group housing can lead to multiple-sired litters, making the maintenance of genetic diversity over time difficult to manage.
Collapse
Affiliation(s)
- Tracey Russell
- School of Life and Environmental Science, The University of Sydney, Sydney, NSW, Australia
| | - Amanda Lane
- School of Life and Environmental Science, The University of Sydney, Sydney, NSW, Australia
| | - Judy Clarke
- Tasmanian Department of Primary Industries, Parks, Water and Environment, Hobart, TAS, Australia
| | - Carolyn Hogg
- School of Life and Environmental Science, The University of Sydney, Sydney, NSW, Australia
| | - Katrina Morris
- The Roslin Institute and R(D)SVS, University of Edinburgh, Easter Bush, Midlothian, UK
| | - Tamara Keeley
- School of Agriculture and Food Sciences, The University of Queensland, Gatton, QLD, Australia
| | - Thomas Madsen
- School of Biological Sciences, University of Wollongong, Wollongong, NSW, Australia
- Centre for Integrative Ecology, School of Life and Environmental Sciences, Deakin University, Waurn Ponds, VIC, Australia
| | - Beata Ujvari
- Centre for Integrative Ecology, School of Life and Environmental Sciences, Deakin University, Waurn Ponds, VIC, Australia
| |
Collapse
|
40
|
Jacobs C, Gao J, Wang X, Ready N, Clarke J, Tong B, Kelsey C, Suneja G, Torok J. Definitive Radiotherapy for Inoperable Stage IIB Non-Small Cell Lung Cancer: Patterns of Care and Comparative Effectiveness Analyses Using the National Cancer Database. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.01.042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
41
|
Shultz SP, Hughes-Oliver C, Wells D, Sheerin K, Fink PW, Handsfield GG, Hébert-Losier K, Clarke J, Queen RM. Can research align with service? Lessons learned from the Big Experiment and National Biomechanics Day. J Biomech 2019; 87:202-205. [PMID: 30910361 DOI: 10.1016/j.jbiomech.2019.03.006] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2019] [Accepted: 03/09/2019] [Indexed: 10/27/2022]
Abstract
Public engagement is an important role for the university academic, but is often neglected due to perceived lack of time and prioritized commitments in research and teaching. Yet, public engagement events offer an untapped opportunity for researchers to collect data from members of the general public who arrive on site at university labs. These engagement events could allow for data collection as part of didactic and demonstrative outreach events to be used in research and science. In this proof of concept study, a collaborative group of international researchers investigated the feasibility of embedding research quality assessment into events surrounding National Biomechanics Day. The Big Experiment collected data on 501 secondary school students (age range: 13 to 18 years) across 9 university sites within a 24-hour period. Data included maximal vertical jump height and self-reported physical activity levels. Vertical jump height was positively correlated to participant height, but not age or body mass. Very physically active students had significantly higher vertical jump heights than individuals who reported being somewhat or not physically active. This feasibility project demonstrates that with substantial preparation and a simple research design, focused research questions can be incorporated into educational outreach initiatives and ultimately provide a rich data source.
Collapse
Affiliation(s)
- S P Shultz
- School of Sport and Exercise, Massey University, New Zealand; Kinesiology Department, Seattle University, Seattle, WA, USA.
| | - C Hughes-Oliver
- Kevin P. Granata Biomechanics Lab, Department of Biomedical Engineering and Mechanics, Virginia Tech, Blacksburg, VA, USA
| | - D Wells
- Sports Performance Research Institute New Zealand (SPRINZ), School of Sport and Recreation, Auckland University of Technology, Auckland, New Zealand
| | - K Sheerin
- Sports Performance Research Institute New Zealand (SPRINZ), School of Sport and Recreation, Auckland University of Technology, Auckland, New Zealand
| | - P W Fink
- School of Sport and Exercise, Massey University, New Zealand
| | - G G Handsfield
- Auckland Bioengineering Institute, University of Auckland, Auckland, New Zealand
| | - K Hébert-Losier
- Faculty of Health, Sport and Human Performance, University of Waikato, Adams Centre for High Performance, Tauranga, New Zealand
| | - J Clarke
- School of Health Sciences, University of Canterbury, Christchurch, New Zealand
| | - R M Queen
- Kevin P. Granata Biomechanics Lab, Department of Biomedical Engineering and Mechanics, Virginia Tech, Blacksburg, VA, USA
| |
Collapse
|
42
|
Grankvist R, Jensen-Urstad M, Clarke J, Lehtinen M, Little P, Lundberg J, Arnberg F, Jonsson S, Chien KR, Holmin S. Superselective endovascular tissue access using trans-vessel wall technique: feasibility study for treatment applications in heart, pancreas and kidney in swine. J Intern Med 2019; 285:398-406. [PMID: 30289186 DOI: 10.1111/joim.12841] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
OBJECTIVES With the emergence of targeted cell transplantation and gene therapy, there is a need for minimally invasive tissue access to facilitate delivery of therapeutic substrate. The objective of this study was to demonstrate the suitability of an endovascular device which is able to directly access tissue and deliver therapeutic agent to the heart, kidney and pancreas without need to seal the penetration site. METHODS In vivo experiments were performed in 30 swine, including subgroups with follow-up to evaluate complications. The previously described trans-vessel wall (VW) device was modified to be sharper and not require tip detachment to seal the VW. Injections into targets in the heart (n = 13, 24-h follow-up n = 5, 72-h follow-up n = 3), kidney (n = 8, 14-day follow-up n = 3) and pancreas (n = 5) were performed. Some animals were used for multiple organ injections. Follow-up consisted of clinical monitoring, angiography and necropsy. Transvenous (in heart) and transarterial approaches (in heart, kidney and pancreas) were used. Injections were targeted towards the subepicardium, endomyocardium, pancreas head and tail, and kidney subcapsular space and cortex. RESULTS Injections were successful in target organs, visualized by intraparenchymal contrast on fluoroscopy and by necropsy. No serious complications (defined as heart failure or persistent arrhythmia, haemorrhage requiring treatment or acute kidney injury) were encountered over a total of 157 injections. CONCLUSIONS The trans-VW device can achieve superselective injections to the heart, pancreas and kidney for delivery of therapeutic substances without tip detachment. All parts of these organs including the subepicardium, pancreas tail and renal subcapsular space can be efficiently reached.
Collapse
Affiliation(s)
- R Grankvist
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.,Department of Neuroradiology, Karolinska University Hospital, Stockholm, Sweden
| | - M Jensen-Urstad
- Department of Cardiology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
| | - J Clarke
- Department of Cell and Molecular Biology and Medicine, Karolinska Institutet, Stockholm, Sweden
| | - M Lehtinen
- Department of Cell and Molecular Biology and Medicine, Karolinska Institutet, Stockholm, Sweden
| | - P Little
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.,Department of Neuroradiology, Karolinska University Hospital, Stockholm, Sweden
| | - J Lundberg
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.,Department of Neuroradiology, Karolinska University Hospital, Stockholm, Sweden
| | - F Arnberg
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.,Department of Neuroradiology, Karolinska University Hospital, Stockholm, Sweden
| | - S Jonsson
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.,Department of Neuroradiology, Karolinska University Hospital, Stockholm, Sweden.,Department of Materials Science and Engineering, Royal Institute of Technology, Stockholm, Sweden
| | - K R Chien
- Department of Cell and Molecular Biology and Medicine, Karolinska Institutet, Stockholm, Sweden
| | - S Holmin
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.,Department of Neuroradiology, Karolinska University Hospital, Stockholm, Sweden
| |
Collapse
|
43
|
Boutan C, Jones M, LaRoque BH, Oblath NS, Cervantes R, Du N, Force N, Kimes S, Ottens R, Rosenberg LJ, Rybka G, Yang J, Carosi G, Woollett N, Bowring D, Chou AS, Khatiwada R, Sonnenschein A, Wester W, Bradley R, Daw EJ, Agrawal A, Dixit AV, Clarke J, O'Kelley SR, Crisosto N, Gleason JR, Jois S, Sikivie P, Stern I, Sullivan NS, Tanner DB, Harrington PM, Lentz E. Piezoelectrically Tuned Multimode Cavity Search for Axion Dark Matter. Phys Rev Lett 2018; 121:261302. [PMID: 30636160 DOI: 10.1103/physrevlett.121.261302] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/22/2018] [Indexed: 06/09/2023]
Abstract
The μeV axion is a well-motivated extension to the standard model. The Axion Dark Matter eXperiment (ADMX) collaboration seeks to discover this particle by looking for the resonant conversion of dark-matter axions to microwave photons in a strong magnetic field. In this Letter, we report results from a pathfinder experiment, the ADMX "Sidecar," which is designed to pave the way for future, higher mass, searches. This testbed experiment lives inside of and operates in tandem with the main ADMX experiment. The Sidecar experiment excludes masses in three widely spaced frequency ranges (4202-4249, 5086-5799, and 7173-7203 MHz). In addition, Sidecar demonstrates the successful use of a piezoelectric actuator for cavity tuning. Finally, this publication is the first to report data measured using both the TM_{010} and TM_{020} modes.
Collapse
Affiliation(s)
- C Boutan
- Pacific Northwest National Laboratory, Richland, Washington 99354, USA
| | - M Jones
- Pacific Northwest National Laboratory, Richland, Washington 99354, USA
| | - B H LaRoque
- Pacific Northwest National Laboratory, Richland, Washington 99354, USA
| | - N S Oblath
- Pacific Northwest National Laboratory, Richland, Washington 99354, USA
| | - R Cervantes
- University of Washington, Seattle, Washington 98195, USA
| | - N Du
- University of Washington, Seattle, Washington 98195, USA
| | - N Force
- University of Washington, Seattle, Washington 98195, USA
| | - S Kimes
- University of Washington, Seattle, Washington 98195, USA
| | - R Ottens
- University of Washington, Seattle, Washington 98195, USA
| | - L J Rosenberg
- University of Washington, Seattle, Washington 98195, USA
| | - G Rybka
- University of Washington, Seattle, Washington 98195, USA
| | - J Yang
- University of Washington, Seattle, Washington 98195, USA
| | - G Carosi
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - N Woollett
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - D Bowring
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A S Chou
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - R Khatiwada
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Sonnenschein
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - W Wester
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - R Bradley
- National Radio Astronomy Observatory, Charlottesville, Virginia 22903, USA
| | - E J Daw
- University of Sheffield, Sheffield S3 7RH, United Kingdom
| | - A Agrawal
- University of Chicago, Illinois 60637, USA
| | - A V Dixit
- University of Chicago, Illinois 60637, USA
| | - J Clarke
- University of California, Berkeley, California 94720, USA
| | - S R O'Kelley
- University of California, Berkeley, California 94720, USA
| | - N Crisosto
- University of Florida, Gainesville, Florida 32611, USA
| | - J R Gleason
- University of Florida, Gainesville, Florida 32611, USA
| | - S Jois
- University of Florida, Gainesville, Florida 32611, USA
| | - P Sikivie
- University of Florida, Gainesville, Florida 32611, USA
| | - I Stern
- University of Florida, Gainesville, Florida 32611, USA
| | - N S Sullivan
- University of Florida, Gainesville, Florida 32611, USA
| | - D B Tanner
- University of Florida, Gainesville, Florida 32611, USA
| | | | - E Lentz
- University of Göttingen, Göttingen 37077, Germany
| |
Collapse
|
44
|
Clarke J, Medford S, Islam S, Ramsingh C, Christopher M. Extranodal lymphoma of the tongue, a very rare entity-report of two cases with literature review. Int J Surg Case Rep 2018; 54:70-74. [PMID: 30529948 PMCID: PMC6289947 DOI: 10.1016/j.ijscr.2018.09.055] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2018] [Accepted: 09/30/2018] [Indexed: 12/04/2022] Open
Abstract
The extranodal lymphoma of the base of the tongue is extremely rare. Among the lymphoma of the tongue; B cell lymphoma is more common than T cell lymphoma. It should be included in the differentials in patients with tumors arising from this site. Early detection and treatment can often result in a complete cure and a better long-term survival.
Background Lymphomas are malignant neoplasms of the lymphocyte cell lines affecting the lymph nodes, spleen and other nonhemopoietic tissues. Of the extranodal lymphomas found in the head and neck region, 3–5% of malignant lymphomas arise in the oral and paraoral region, mainly from Waldeyer's ring. The involvement of the base of the tongue is extremely rare. Summarised Case Case 1: 64 year old female who presented initially with an enlarged occipital lymph node which gradually became generalized cervical lymphadenopathy with initial histology confirmed reactive lymphoid hyperplasia. Biopsy of left postero-lateral tongue lesion eventually showed high grade T cell lymphoma. Case 2: 85 year old male presented with history of dysphagia for one year who was found to have a lesion extending from his base of tongue into the nasopharynx. Histology showed a diffuse B cell lymphoma. Discussion Both patients were noted to have lesion of the tongue, but tongue lesions are noted in the literature to be extremely rare. When tongue lymphomas do occur, most are of B-cell origin; the diffuse large-cell variety is the most common. Extranodal lymphomas of the T cell phenotype tend more to be sinonasal in origin than of the tongue, with T cell lymphomas of the tongue being even rarer than B cell lymphomas. Conclusion With regards to tumours arising in the tongue, squamous cell carcinomas are still classified as the most common. Lymphomas however, should still be kept in consideration as a differential diagnosis with regards to lesions arising from this site.
Collapse
Affiliation(s)
- J Clarke
- Department of Otorhinolaryngology and Head and Neck Surgery, San Fernando Teaching Hospital, Trinidad and Tobago; Department of Clinical Surgical Science, University of the West Indies, St. Augustine, Trinidad and Tobago
| | - S Medford
- Department of Otorhinolaryngology and Head and Neck Surgery, San Fernando Teaching Hospital, Trinidad and Tobago; Department of Clinical Surgical Science, University of the West Indies, St. Augustine, Trinidad and Tobago
| | - S Islam
- Department of General Surgery, San Fernando Teaching Hospital, Trinidad and Tobago; Department of Clinical Surgical Science, University of the West Indies, St. Augustine, Trinidad and Tobago.
| | - C Ramsingh
- Department of Otorhinolaryngology and Head and Neck Surgery, San Fernando Teaching Hospital, Trinidad and Tobago; Department of Clinical Surgical Science, University of the West Indies, St. Augustine, Trinidad and Tobago
| | - M Christopher
- Department of Otorhinolaryngology and Head and Neck Surgery, San Fernando Teaching Hospital, Trinidad and Tobago; Department of Clinical Surgical Science, University of the West Indies, St. Augustine, Trinidad and Tobago
| |
Collapse
|
45
|
Chapman C, Hara J, Clarke J, Butowski N, Chang S, Fogh S, Sneed P, Nakamura J, Raleigh D, Braunstein S. Reirradiation of Recurrent High Grade Gliomas: Outcomes and Prognostic Factors. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2018.07.732] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
46
|
Velikova G, Williams LJ, Willis S, Dixon JM, Loncaster J, Hatton M, Clarke J, Kunkler IH, Russell NS, Alhasso A, Adamson D, Algurafi H, Allerton R, Anandadas C, Bahl A, Barraclough L, Barrett-Lee P, Barthakur U, Bedi C, Beresford M, Bishop J, Blackman G, Bliss P, Bloomfield D, Blunt M, Branson T, Brazil L, Brunt A, Chakrabarti A, Chittalie A, Churn M, Clarke J, Cleator S, Crellin P, Danwata F, De-Silva-Minor S, Dhadda A, Eicholz A, Fernando I, Forrest J, Fraser J, Geropantas K, Goodman A, Grieve R, Griffin M, Hadaki M, Hall A, Hatton M, Hicks J, Hignett S, Hogg M, Jyothirmayi R, Khan M, Kumar S, Lawton P, Lee D, Lewinski C, Lim C, Locke I, Loncaster J, Lumsden G, Lupton S, Magee B, Marshall J, Masinghe S, McGregor C, McLennan M, Memtsa P, Milanovic D, Misra V, Mithal N, Mukesh MB, Neal A, Needleman S, Persic M, Quigley M, Raj S, Riddle P, Ritchie D, Roberts F, Robson P, Roe H, Rolles M, Shah N, Sharma R, Sherwin E, Simmonds P, Skailles G, Skaria S, Soe W, Sripadam R, Stevens A, Stockdale A, Storey N, Storey N, Syndikus I, Thorp N, Thorp N, Upadhyay S, Varughese M, Walji N, Welch R, Wells T, Wolstenholme V, Wolstenholme V, Woodings P, Yuille F. Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial. Lancet Oncol 2018; 19:1516-1529. [DOI: 10.1016/s1470-2045(18)30515-1] [Citation(s) in RCA: 30] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2018] [Revised: 06/29/2018] [Accepted: 07/02/2018] [Indexed: 11/12/2022]
|
47
|
Clarke J, Stefaniak V, Batus M, Winfree K, Molife C, Cui Z, Han Y, Tawney M, Bonomi P. P3.01-19 Sequencing of Ramucirumab+Docetaxel Post-Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer Patients. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.1579] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
48
|
Batus M, Molife C, Clarke J, Stefaniak V, Winfree K, Cui Z, Han Y, Tawney M, Bonomi P. P2.01-12 Ramucirumab+Docetaxel Usage Following Rapid Disease Progression in Real World Advanced Non-Small Cell Lung Cancer Patients. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.1066] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
49
|
McMenamin L, Clarke J, Hopkins P. Review: Basics of Anesthesia. Br J Anaesth 2018. [DOI: 10.1016/j.bja.2018.01.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
50
|
Du N, Force N, Khatiwada R, Lentz E, Ottens R, Rosenberg LJ, Rybka G, Carosi G, Woollett N, Bowring D, Chou AS, Sonnenschein A, Wester W, Boutan C, Oblath NS, Bradley R, Daw EJ, Dixit AV, Clarke J, O'Kelley SR, Crisosto N, Gleason JR, Jois S, Sikivie P, Stern I, Sullivan NS, Tanner DB, Hilton GC. Search for Invisible Axion Dark Matter with the Axion Dark Matter Experiment. Phys Rev Lett 2018; 120:151301. [PMID: 29756850 DOI: 10.1103/physrevlett.120.151301] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/04/2018] [Indexed: 05/27/2023]
Abstract
This Letter reports the results from a haloscope search for dark matter axions with masses between 2.66 and 2.81 μeV. The search excludes the range of axion-photon couplings predicted by plausible models of the invisible axion. This unprecedented sensitivity is achieved by operating a large-volume haloscope at subkelvin temperatures, thereby reducing thermal noise as well as the excess noise from the ultralow-noise superconducting quantum interference device amplifier used for the signal power readout. Ongoing searches will provide nearly definitive tests of the invisible axion model over a wide range of axion masses.
Collapse
Affiliation(s)
- N Du
- University of Washington, Seattle, Washington 98195, USA
| | - N Force
- University of Washington, Seattle, Washington 98195, USA
| | - R Khatiwada
- University of Washington, Seattle, Washington 98195, USA
| | - E Lentz
- University of Washington, Seattle, Washington 98195, USA
| | - R Ottens
- University of Washington, Seattle, Washington 98195, USA
| | - L J Rosenberg
- University of Washington, Seattle, Washington 98195, USA
| | - G Rybka
- University of Washington, Seattle, Washington 98195, USA
| | - G Carosi
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - N Woollett
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - D Bowring
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A S Chou
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Sonnenschein
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - W Wester
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - C Boutan
- Pacific Northwest National Laboratory, Richland, Washington 99354, USA
| | - N S Oblath
- Pacific Northwest National Laboratory, Richland, Washington 99354, USA
| | - R Bradley
- National Radio Astronomy Observatory, Charlottesville, Virginia 22903, USA
| | - E J Daw
- University of Sheffield, Sheffield S3 7RH, United Kingdom
| | - A V Dixit
- University of Chicago, Illinois 60637, USA
| | - J Clarke
- University of California, Berkeley, California 94720, USA
| | - S R O'Kelley
- University of California, Berkeley, California 94720, USA
| | - N Crisosto
- University of Florida, Gainesville, Florida 32611, USA
| | - J R Gleason
- University of Florida, Gainesville, Florida 32611, USA
| | - S Jois
- University of Florida, Gainesville, Florida 32611, USA
| | - P Sikivie
- University of Florida, Gainesville, Florida 32611, USA
| | - I Stern
- University of Florida, Gainesville, Florida 32611, USA
| | - N S Sullivan
- University of Florida, Gainesville, Florida 32611, USA
| | - D B Tanner
- University of Florida, Gainesville, Florida 32611, USA
| | - G C Hilton
- National Institute of Standards and Technology, Boulder, Colorado 80305, USA
| |
Collapse
|